Pengaruh Pemberian Rejimen Antiretroviral Yang Mengandung Zidovudine Atau Tenofovir Terhadap Kadar Lipid Pada Orang Dengan Hiv Aids (Odha)
53
Lampiran 1: Surat Persetujuan Komite Etik
Universitas Sumatera Utara
54
Lampiran 2
LEMBAR PENJELASAN KEPADA CALON SUBJEK PENELITIAN
Selamat pagi/siang Bapak/Ibu/Saudara/I, pada hari ini saya, dr.Eva
Roswati, peserta Pendidikan Pasca Sarjana Ilmu Penyakit Dalam / Magister
Klinik FK USU Medan akan melakukan penelitian yang berjudul ” Pengaruh
pemberian rejimen antiretroviral (ARV) yang mengandung Zidovudine atau
Tenofovir terhadap kadar lipid pada orang dengan HIV/AIDS (ODHA)”.
Penelitian ini bertujuan melihat pengaruh pemberian obat antiretroviral yang
mengandung Zidovudine atau Tenofovir selama 6 bulan terhadap kadar lipid
serum. Sebagai informasi, yang dikatakan sebagai penderita HIV-AIDS adalah
subyek yang terinfeksi virus HIV yang memerlukan terapi obat anti virus untuk
mengobati penyakitnya. Diperlukan kepatuhan untuk meminum obat anti virus
tersebut agar keberhasilan terapi dapat tercapai. Namun demikian, pemberian obat
anti virus juga mempengaruhi kadar lipid. Untuk itu peneliti ingin mengetahui
apakah ada hubungan antara obat tersebut dengan kadar lipid .
Bapak/Ibu/Saudara/Saudari yang bersedia mengikuti penelitian ini
nantinya akan diminta mengisi surat persetujuan ikut dalam penelitian, mengikuti
wawancara untuk mencari adanya hal-hal yang dapat mengganggu penelitian.
Untuk penelitian ini akan dilakukan pengambilan darah pada daerah lipatan siku
Bapak/Ibu/Saudara/i sebanyak ±15 cc (1 sendok makan) oleh ahlinya untuk
pemeriksaan darah rutin, fungsi hati, fungsi ginjal, kadar glukosa darah, kadar
lipid setelah Bapak/Ibu berpuasa 12-16jam semalam sebelum pengambilan darah.
Di akhir minggu ke 24 nantinya akan dilakukan pemeriksaan ulangan untuk
menilai efek apakah terdapat pengaruh dalam hal ini: kadar lipid dari pemberian
obat antiretroviral yang telah Bapak/Ibu/Saudara/Saudari minum. Segala biaya
pemeriksaan laboratorium menjadi tanggung jawab peneliti. Bila masih terdapat
pertanyaan atau keluhan sewaktu penelitian ini berjalan, maka
Bapak/Ibu/Saudara/Saudari dapat menghubungi saya pada:
Nama
: dr.Eva Roswati
Alamat
: Jl. Gajah Mada No. 14 Medan
Telepon
: 08116074047
Atas Perhatian Bapak/Ibu, Saudara/i saya ucapkan terima kasih.
Peneliti,
(dr.Eva Roswati)
Universitas Sumatera Utara
55
Lampiran 3
LEMBAR PERSETUJUAN SETELAH PENJELASAN
(INFORMED CONSENT)
Saya yang bertandatangan di bawah ini:
Nama
: ............................................................................
Alamat
: ............................................................................
Umur
: ............................................................................
Jenis Kelamin
: Laki-laki/ Perempuan
No Telp
: ............................................................................
Setelah mendapat penjelasan dari peneliti tentang kebaikan dan keburukan
prosedur penelitian ini, saya menyatakan bersedia ikut serta dalam penelitian
tentang
“Pengaruh
pemberian
rejimen
antiretroviral
(ARV)
yang
mengandung Zidovudine atau Tenofovir terhadap kadar lipid pada orang
dengan HIV/AIDS (ODHA)”. Apabila sewaktu-waktu saya mengudurkan diri
dari penelitian ini, kepada saya tidak dituntut apapun.
Demikian surat persetujuan bersedia ikut dalam penelitian ini saya buat untuk
dapat dipergunakan seperlunya.
Medan, ……………..
Saksi
(_________________ )
Yang memberi pernyataan
(_________________ )
Universitas Sumatera Utara
56
Lampiran 4
KERTAS KERJA PROFIL PESERTA PENELITIAN
I. IDENTITAS PRIBADI.
Nama
Umur
Jenis Kelamin
Pendidikan Terakhir
Pekerjaan
Alamat
Faktor resiko
Nomor Rekam Medis
: .............................
: .............................
: Laki-laki/Perempuan.
: .............................
: .............................
: .............................
: ……………………
: ……………………
II.PEMERIKSAAN FISIK
Parameter Antropometri
Berat Badan (kg)
Tinggi Badan (m2)
Indeks Massa Tubuh (kg/m2 )
Hasil
III.PEMERIKSAAN LABORATORIUM
Parameter Metabolik
Hemoglobin
Hematokrit
Trombosit
Lekosit
Hitung jenis lekosit
Ureum
Kreatinin
SGOT
SGPT
Kadar Glukosa Darah
CD4
Kolesterol total
Trigliserid
HDL kolesterol
LDL kolesterol
EKG
Hasil
Universitas Sumatera Utara
57
Lampiran 5
DAFTAR RIWAYAT HIDUP
I.
II.
Identitas Pribadi
Nama
: dr. Eva Roswati
Tempat/Tgl Lahir
: Jakarta/ 24 November 1977
Suku/Bangsa
: Batak/ Indonesia
Agama
: Kristen Protestan
Status
: Menikah
Alamat
: Jl. Gajah Mada Gg. Sersan No. 14 Medan
Telpon Selluler
: 08116074047
Keluarga
Nama suami
: Ir. Sarma Aries H. Lumban Gaol
Anak
: 1. Josh Richard Lumban Gaol
2. Daireann Ersah Lumban Gaol
III.
IV.
Pendidikan
SDN 09 Pagi Ragunan, Jakarta
Tamat Tahun 1989
SMPN 175 Jagakarsa, Jakarta
Tamat Tahun 1992
SMAN 28 Pasar Minggu, Jakarta
Tamat Tahun 1995
Fakultas Kedokteran Universitas Sumatera Utara
Tamat Tahun 2001
PPDS Ilmu Penyakit Dalam FK USU
2010 - sekarang
Riwayat Pekerjaan
Dokter ICU RSPAD Gatot Soebroto, Jakarta
Dokter PTT RSU Dr. Hadrianus Sinaga Pangururan, Samosir
Dokter UGD RSPAD Gatot Soebroto, Jakarta
Staf Pusat Penanggulangan Krisis Kemenkes RI, Jakarta
Universitas Sumatera Utara
58
V.
Perkumpulan Profesi
Anggota IDI Cabang Medan
Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI)
VI.
Tulisan Ilmiah
1. Diagnosis dan Tatalaksana Koagulasi Intravaskular Diseminata pada
Sepsis
2. Insufisiensi adrenal pada pasien dengan penyakit kritis
3. Dispepsia Tukak : Diagnosis dan Manajemen
4. Makna Klinis Kadar Troponin T pada penyakit jantung
5. Pemakaian Obat-obat sistemik pada penyakit ginjal kronik
6. Acute Respiratory Distress Syndrome
7. Manifestasi Klinis dari Alergi Makanan
8. Penggunaan sistem skor sebagai panduan thromboprofilaksis pada
populasi ibu hamil dengan resiko tinggi
9. Bagaimana manifestasi jiwa yang sehat
VII. Publikasi Ilmiah
1. Sindroma
Cushing
Iatrogenik
dan
Dermatitis
Eksfoliativa
Generalisata: Laporan Kasus. 4 th Endocrinology & Diabetes Forum
Of Sumatera Region. Banda Aceh, 2012.
2. Pengalaman Menangani Kasus Serial Malaria Berat di RS H.Adam
Malik Tahun 2011 – Mei 2012 : Laporan Kasus. PETRI, Banda Aceh,
2012
VIII. Partisipasi Dalam Kegiatan Ilmiah
1. Peserta Simposium “The New Option of Insulin Resistance Treatment
in Type 2 Diabetes”, Hermes Palace Hotel Medan, 20 November 2011
2. Panitia “Current Challenges Management on Infections”. PETRISUMUT. Hotel Danau Toba International. Medan 26-27 November
2011.
Universitas Sumatera Utara
59
3. Peserta Simposium “Rationale Strategy in the Management of
Pancreatic B Dysfunction and Role of Oral Incretin Based Therapy in
Type 2 Diabetes Mellitus”, Hotel J.W. Marriott Medan, 29 Januari
2012.
4. Peserta Simposium The New Direction in The Treatment of Type 2
Diabetes Melitus “A New Novel DPP-4 Inhibitor For T2DM
Treatment”, Hotel J.W. Marriott Medan, 1 April 2012
5. Peserta Roadshow Hipertensi PB PAPDI “The Next Big Target in
Hypertension: Controlling All Key BP Parameters”, Hotel J.W.
Marriott Medan, 28 April 2012
6. Peserta Seminar dan Lokakarya Sehari: Comperhensive Management
of Nausea-Vomiting and Acid Related Diseases, 5 Mei 2012.
7. Peserta Simposium “Diagnostik dan Manajemen Terkini di Bidang
Ilmu Penyakit Dalam, Fokus pada Infeksi”. PIT Penyakit Dalam XIII
& Infection Update V. Hotel Danau Toba Internasional. Medan, 9-10
Juni 2012.
8. Peserta Simposium Kongres Nasional XV Perhimpunan Dokter
Spesialis Penyakit Dalam Indonesia (KOPAPDI XV), Hotel J.W.
Marriott dan Hotel Grand Aston Medan, 12-15 Desember 2012
9. Peserta Workshop USG PAD, FEDS V, Hotel Grand Aston Medan,
Februari 2013
10. Panitia Workshop & Simposium “Meningkatkan Kemampuan Dalam
Menghadapi Penyakit Infeksi Masa Kini” Infection Update VI. PETRI
SUMUT. Hotel Danau Toba Internasional. Medan 6-7 September
2013.
11. Peserta Workshop “USG”. Pertemuan Ilmiah Tahunan Ilmu Penyakit
Dalam XIV & Gastroentero-Hepatologi Update XI. Hotel Tiara
Convention Center. Medan 12-14 September 2013.
12. Peserta Workshop & Simposium Medan Chest and Clinical
Immunology (MCCI). Hotel Tiara Convention Center. Medan, 5-7
Desember 2013.
Universitas Sumatera Utara
60
Lampiran 6
HASIL STATISTIK
Karakteristik Dasar Subjek Penelitian
Crosstab Jenis kelamin
rejimen
Naive
jk
Laki-laki
Count
Total
Zidovudine
Tenofovir
11
12
14
37
12,3
12,3
12,3
37,0
% within jk
29,7%
32,4%
37,8%
100,0%
% within rejimen
52,4%
57,1%
66,7%
58,7%
Count
10
9
7
26
Expected Count
8,7
8,7
8,7
26,0
% within jk
38,5%
34,6%
26,9%
100,0%
% within rejimen
47,6%
42,9%
33,3%
41,3%
21
21
21
63
21,0
21,0
21,0
63,0
33,3%
33,3%
33,3%
100,0%
100,0%
100,0%
100,0%
100,0%
Expected Count
Perempuan
Total
Count
Expected Count
% within jk
% within rejimen
Chi-Square Tests
Asymp. Sig. (2Value
df
sided)
a
2
,632
Likelihood Ratio
,926
2
,629
Linear-by-Linear Association
,870
1
,351
Pearson Chi-Square
N of Valid Cases
,917
63
a. 0 cells (0,0%) have expected count less than 5. The minimum expected count is 8,67.
Universitas Sumatera Utara
61
Crosstab Pendidikan
rejimen
Naive
pendidikan
SD
Count
1
7
2,3
2,3
2,3
7,0
14,3%
71,4%
14,3%
100,0%
4,8%
23,8%
4,8%
11,1%
4
1
1
6
2,0
2,0
2,0
6,0
% within pendidikan
66,7%
16,7%
16,7%
100,0%
% within rejimen
19,0%
4,8%
4,8%
9,5%
11
8
11
30
10,0
10,0
10,0
30,0
% within pendidikan
36,7%
26,7%
36,7%
100,0%
% within rejimen
52,4%
38,1%
52,4%
47,6%
2
1
0
3
1,0
1,0
1,0
3,0
66,7%
33,3%
0,0%
100,0%
9,5%
4,8%
0,0%
4,8%
3
6
8
17
5,7
5,7
5,7
17,0
% within pendidikan
17,6%
35,3%
47,1%
100,0%
% within rejimen
14,3%
28,6%
38,1%
27,0%
21
21
21
63
21,0
21,0
21,0
63,0
33,3%
33,3%
33,3%
100,0%
100,0%
100,0%
100,0%
100,0%
% within rejimen
Count
Expected Count
Count
Expected Count
AKADEMI
Count
Expected Count
% within pendidikan
% within rejimen
SARJANA
Count
Expected Count
Total
Total
5
% within pendidikan
SMA
Tenofovir
1
Expected Count
SMP
Zidovudine
Count
Expected Count
% within pendidikan
% within rejimen
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases
df
sided)
12,407a
8
,134
12,788
8
,119
1,779
1
,182
63
a. 9 cells (60,0%) have expected count less than 5. The minimum
expected count is 1,00.
Universitas Sumatera Utara
62
Crosstab Pekerjaan
rejimen
Naive
pekerjaan
swasta
Count
9
24
8,0
8,0
8,0
24,0
% within pekerjaan
29,2%
33,3%
37,5%
100,0%
% within rejimen
33,3%
38,1%
42,9%
38,1%
5
2
2
9
3,0
3,0
3,0
9,0
% within pekerjaan
55,6%
22,2%
22,2%
100,0%
% within rejimen
23,8%
9,5%
9,5%
14,3%
2
4
3
9
3,0
3,0
3,0
9,0
22,2%
44,4%
33,3%
100,0%
9,5%
19,0%
14,3%
14,3%
2
0
1
3
1,0
1,0
1,0
3,0
66,7%
0,0%
33,3%
100,0%
9,5%
0,0%
4,8%
4,8%
3
1
1
5
1,7
1,7
1,7
5,0
% within pekerjaan
60,0%
20,0%
20,0%
100,0%
% within rejimen
14,3%
4,8%
4,8%
7,9%
2
4
5
11
3,7
3,7
3,7
11,0
18,2%
36,4%
45,5%
100,0%
9,5%
19,0%
23,8%
17,5%
Count
0
1
0
1
Expected Count
,3
,3
,3
1,0
% within pekerjaan
0,0%
100,0%
0,0%
100,0%
% within rejimen
0,0%
4,8%
0,0%
1,6%
Count
0
1
0
1
Expected Count
,3
,3
,3
1,0
% within pekerjaan
0,0%
100,0%
0,0%
100,0%
% within rejimen
0,0%
4,8%
0,0%
1,6%
21
21
21
63
21,0
21,0
21,0
63,0
Count
Count
Expected Count
% within pekerjaan
% within rejimen
Petani
Count
Expected Count
% within pekerjaan
% within rejimen
PNS
Count
Expected Count
Swasta
Count
Expected Count
% within pekerjaan
% within rejimen
Supir
Mahasiswa
Total
Total
8
Expected Count
IRT
Tenofovir
7
Expected Count
Tidak Bekerja
Zidovudine
Count
Expected Count
Universitas Sumatera Utara
63
% within pekerjaan
% within rejimen
33,3%
33,3%
33,3%
100,0%
100,0%
100,0%
100,0%
100,0%
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
df
14
,623
12,818
14
,541
,050
1
,824
11,789
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases
sided)
a
63
a. 21 cells (87,5%) have expected count less than 5. The minimum
expected count is ,33.
Crosstab Faktor Risiko
rejimen
Naive
FR
Heteroseksual
Count
Transfusi
15
49
16,3
16,3
16,3
49,0
% within FR
34,7%
34,7%
30,6%
100,0%
% within rejimen
81,0%
81,0%
71,4%
77,8%
0
2
5
7
2,3
2,3
2,3
7,0
% within FR
0,0%
28,6%
71,4%
100,0%
% within rejimen
0,0%
9,5%
23,8%
11,1%
Count
0
1
0
1
Expected Count
,3
,3
,3
1,0
% within FR
0,0%
100,0%
0,0%
100,0%
% within rejimen
0,0%
4,8%
0,0%
1,6%
Count
1
0
0
1
Expected Count
,3
,3
,3
1,0
100,0%
0,0%
0,0%
100,0%
4,8%
0,0%
0,0%
1,6%
2
0
1
3
1,0
1,0
1,0
3,0
66,7%
0,0%
33,3%
100,0%
9,5%
0,0%
4,8%
4,8%
1
1
0
2
Count
% within FR
% within rejimen
IDU
Count
Expected Count
% within FR
% within rejimen
Hetero Tatto
Total
17
Expected Count
Bisexual
Tenofovir
17
Expected Count
Homoseksual
Zidovudine
Count
Universitas Sumatera Utara
64
Expected Count
% within FR
,7
,7
,7
2,0
50,0%
50,0%
0,0%
100,0%
4,8%
4,8%
0,0%
3,2%
21
21
21
63
21,0
21,0
21,0
63,0
33,3%
33,3%
33,3%
100,0%
100,0%
100,0%
100,0%
100,0%
% within rejimen
Total
Count
Expected Count
% within FR
% within rejimen
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
df
10
,247
15,959
10
,101
,726
1
,394
12,592
Likelihood Ratio
sided)
a
Linear-by-Linear Association
N of Valid Cases
63
a. 15 cells (83,3%) have expected count less than 5. The minimum
expected count is ,33.
Descriptives Usia, IMT dan CD4
rejimen
usia
Naive
Statistic
Mean
35,2381
95% Confidence Interval for
Lower Bound
31,3786
Mean
Upper Bound
39,0976
5% Trimmed Mean
34,9259
Median
33,0000
Variance
1,85023
71,890
Std. Deviation
Zidovudine
Std. Error
8,47883
Minimum
22,00
Maximum
54,00
Range
32,00
Interquartile Range
11,00
Skewness
,826
,501
Kurtosis
,105
,972
36,3810
2,14640
Mean
95% Confidence Interval for
Lower Bound
31,9036
Mean
Upper Bound
40,8583
5% Trimmed Mean
35,9233
Median
35,0000
Variance
96,748
Universitas Sumatera Utara
65
Std. Deviation
Tenofovir
9,83604
Minimum
21,00
Maximum
60,00
Range
39,00
Interquartile Range
13,50
Skewness
,893
,501
Kurtosis
,410
,972
33,8571
2,23744
Mean
95% Confidence Interval for
Lower Bound
29,1899
Mean
Upper Bound
38,5244
5% Trimmed Mean
33,1164
Median
30,0000
Variance
105,129
Std. Deviation
10,25322
Minimum
21,00
Maximum
60,00
Range
39,00
Interquartile Range
IMT
Naive
8,00
Skewness
1,534
,501
Kurtosis
1,959
,972
20,7190
,65526
Mean
95% Confidence Interval for
Lower Bound
19,3522
Mean
Upper Bound
22,0859
5% Trimmed Mean
20,6254
Median
21,2000
Variance
9,017
Std. Deviation
3,00277
Minimum
15,90
Maximum
27,30
Range
11,40
Interquartile Range
3,90
Skewness
,165
,501
-,037
,972
23,2000
,75763
Kurtosis
Zidovudine
Mean
95% Confidence Interval for
Lower Bound
21,6196
Mean
Upper Bound
24,7804
5% Trimmed Mean
23,0767
Median
22,8000
Universitas Sumatera Utara
66
Variance
12,054
Std. Deviation
Tenofovir
3,47189
Minimum
17,60
Maximum
31,00
Range
13,40
Interquartile Range
3,90
Skewness
,775
,501
Kurtosis
,830
,972
22,0333
,73515
Mean
95% Confidence Interval for
Lower Bound
20,4998
Mean
Upper Bound
23,5668
5% Trimmed Mean
21,8471
Median
21,8000
Variance
11,349
Std. Deviation
CD4
Naive
3,36888
Minimum
17,10
Maximum
30,40
Range
13,30
Interquartile Range
3,65
Skewness
,962
,501
Kurtosis
,897
,972
152,8571
30,47077
Mean
95% Confidence Interval for
Lower Bound
89,2962
Mean
Upper Bound
216,4181
5% Trimmed Mean
143,7090
Median
136,0000
Variance
19497,829
Std. Deviation
139,63463
Minimum
7,00
Maximum
467,00
Range
460,00
Interquartile Range
239,50
Skewness
Kurtosis
Zidovudine
Mean
,772
,501
-,427
,972
333,7143
31,44369
95% Confidence Interval for
Lower Bound
268,1239
Mean
Upper Bound
399,3047
5% Trimmed Mean
330,6085
Universitas Sumatera Utara
67
Median
316,0000
Variance
20762,814
Std. Deviation
144,09308
Minimum
92,00
Maximum
633,00
Range
541,00
Interquartile Range
222,00
Skewness
,243
,501
-,360
,972
306,7143
44,09493
Kurtosis
Tenofovir
Mean
95% Confidence Interval for
Lower Bound
214,7339
Mean
Upper Bound
398,6947
5% Trimmed Mean
291,8122
Median
260,0000
Variance
40831,614
Std. Deviation
202,06834
Minimum
84,00
Maximum
799,00
Range
715,00
Interquartile Range
272,50
Skewness
1,225
,501
Kurtosis
1,100
,972
Tests of Normality Usia, IMT, CD4
Kolmogorov-Smirnova
rejimen
usia
IMT
CD4
Statistic
Naive
df
,138
Shapiro-Wilk
Sig.
Statistic
df
Sig.
21
,200*
,923
21
,098
*
Zidovudine
,148
21
,200
,926
21
,115
Tenofovir
,227
21
,006
,830
21
,002
Naive
,164
21
,144
,958
21
,486
*
Zidovudine
,112
21
,200
,939
21
,206
Tenofovir
,171
21
,113
,930
21
,139
Naive
,165
21
,138
,892
21
,024
*
Zidovudine
,111
21
,200
,974
21
,810
Tenofovir
,158
21
,185
,876
21
,012
*. This is a lower bound of the true significance.
a. Lilliefors Significance Correction
Universitas Sumatera Utara
68
Profil Lipid berdasarkan rejimen pengobatan
Descriptives kadar profil lipid
rejimen
kolest
Naive
Statistic
Mean
145,2857
95% Confidence Interval for
Lower Bound
131,9491
Mean
Upper Bound
158,6223
5% Trimmed Mean
142,7354
Median
138,0000
Variance
29,29871
Minimum
99,00
Maximum
239,00
Range
140,00
Interquartile Range
29,50
Skewness
1,685
,501
Kurtosis
4,431
,972
189,7143
5,38169
Mean
95% Confidence Interval for
Lower Bound
178,4883
Mean
Upper Bound
200,9403
5% Trimmed Mean
189,9048
Median
195,0000
Variance
608,214
Std. Deviation
Tenofovir
6,39350
858,414
Std. Deviation
Zidovudine
Std. Error
24,66200
Minimum
144,00
Maximum
232,00
Range
88,00
Interquartile Range
39,00
Skewness
-,031
,501
Kurtosis
-,856
,972
200,8095
11,31342
Mean
95% Confidence Interval for
Lower Bound
177,2101
Mean
Upper Bound
224,4089
5% Trimmed Mean
201,7116
Median
217,0000
Variance
2687,862
Std. Deviation
51,84459
Universitas Sumatera Utara
69
trigliserid
Naive
Zidovudine
Minimum
105,00
Maximum
281,00
Range
176,00
Interquartile Range
82,50
Skewness
-,394
,501
Kurtosis
-,832
,972
123,4286
8,44691
Mean
95% Confidence Interval for
Lower Bound
105,8086
Mean
Upper Bound
141,0485
5% Trimmed Mean
123,2937
Median
129,0000
Variance
1498,357
Std. Deviation
38,70862
Minimum
53,00
Maximum
197,00
Range
144,00
Interquartile Range
56,00
Skewness
-,151
,501
Kurtosis
-,455
,972
123,0000
11,97299
Mean
95% Confidence Interval for
Lower Bound
98,0248
Mean
Upper Bound
147,9752
5% Trimmed Mean
121,0873
Median
113,0000
Variance
3010,400
Std. Deviation
54,86711
Minimum
46,00
Maximum
235,00
Range
189,00
Interquartile Range
84,50
Skewness
Kurtosis
Tenofovir
Mean
,620
,501
-,410
,972
153,3333
20,41957
95% Confidence Interval for
Lower Bound
110,7389
Mean
Upper Bound
195,9278
5% Trimmed Mean
148,9815
Median
129,0000
Variance
8756,133
Std. Deviation
93,57421
Universitas Sumatera Utara
70
Minimum
30,00
Maximum
355,00
Range
325,00
Interquartile Range
117,50
Skewness
Kurtosis
HDL
Naive
Mean
,487
,972
30,9524
2,08335
Lower Bound
26,6066
Mean
Upper Bound
35,2982
5% Trimmed Mean
30,8042
Median
34,0000
91,148
Std. Deviation
9,54713
Minimum
12,00
Maximum
53,00
Range
41,00
Interquartile Range
13,00
Skewness
-,142
,501
,556
,972
49,6667
2,75451
Kurtosis
Mean
95% Confidence Interval for
Lower Bound
43,9209
Mean
Upper Bound
55,4125
5% Trimmed Mean
49,6190
Median
47,0000
Variance
159,333
Std. Deviation
12,62273
Minimum
29,00
Maximum
71,00
Range
42,00
Interquartile Range
23,00
Skewness
Kurtosis
Tenofovir
,501
95% Confidence Interval for
Variance
Zidovudine
1,076
Mean
,193
,501
-,979
,972
44,9524
2,97408
95% Confidence Interval for
Lower Bound
38,7486
Mean
Upper Bound
51,1562
5% Trimmed Mean
44,5185
Median
42,0000
Variance
185,748
Std. Deviation
13,62893
Universitas Sumatera Utara
71
Minimum
25,00
Maximum
73,00
Range
48,00
Interquartile Range
17,50
Skewness
Kurtosis
LDL
Naive
Mean
-,398
,972
91,5714
5,68103
Lower Bound
79,7210
Mean
Upper Bound
103,4219
5% Trimmed Mean
89,8413
Median
88,0000
Variance
677,757
26,03377
Minimum
55,00
Maximum
160,00
Range
105,00
Interquartile Range
23,00
Skewness
1,121
,501
Kurtosis
1,429
,972
123,0000
6,36134
Mean
95% Confidence Interval for
Lower Bound
109,7305
Mean
Upper Bound
136,2695
5% Trimmed Mean
121,1190
Median
122,0000
Variance
849,800
Std. Deviation
Tenofovir
,501
95% Confidence Interval for
Std. Deviation
Zidovudine
,504
29,15133
Minimum
71,00
Maximum
211,00
Range
140,00
Interquartile Range
36,50
Skewness
1,094
,501
Kurtosis
3,165
,972
124,5238
8,15844
Mean
95% Confidence Interval for
Lower Bound
107,5056
Mean
Upper Bound
141,5420
5% Trimmed Mean
125,5794
Median
130,0000
Universitas Sumatera Utara
72
Variance
1397,762
Std. Deviation
37,38665
Minimum
46,00
Maximum
183,00
Range
137,00
Interquartile Range
58,50
Skewness
-,371
,501
Kurtosis
-,571
,972
Tests of Normality
Kolmogorov-Smirnova
rejimen
kolest
trigliserid
HDL
LDL
Naive
Statistic
,150
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
21
,200*
,869
21
,009
*
Zidovudine
,109
21
,200
,970
21
,733
Tenofovir
,146
21
,200*
,955
21
,417
21
*
,981
21
,935
*
Naive
,098
,200
Zidovudine
,135
21
,200
,941
21
,229
Tenofovir
,203
21
,024
,880
21
,015
Naive
,163
21
,150
,948
21
,313
*
Zidovudine
,115
21
,200
,953
21
,387
Tenofovir
,157
21
,190
,946
21
,284
Naive
,168
21
,124
,908
21
,050
21
*
,918
21
,078
*
,964
21
,591
Zidovudine
Tenofovir
,140
,135
21
,200
,200
Universitas Sumatera Utara
73
Uji Kruskal Wallis
Universitas Sumatera Utara
74
UJI ANOVA
Sum of Squares
IMT
Between Groups
df
2
32,353
Within Groups
648,399
60
10,807
Total
713,104
62
335648571428,5
Total
Sig.
2,994
,058
13,683
,000
7,451
,001
60 5594142857,143
71
361280857142,8
62
57
LDL
F
64,705
Within Groups
HDL
Mean Square
Between Groups
3979,143
2
1989,571
Within Groups
8724,571
60
145,410
Total
12703,714
62
Between Groups
14531,556
2
7265,778
Within Groups
58506,381
60
975,106
Total
73037,937
62
Post Hoc Tests
Multiple Comparisons
Bonferroni
Dependent
95% Confidence Interval
Mean Difference (I-
Variable
(I) rejimen
(J) rejimen
Lower Bound
Upper Bound
IMT
Naive
Zidovudine
-2,48095
1,01450
,052
-4,9796
,0177
Tenofovir
-1,31429
1,01450
,600
-3,8129
1,1844
2,48095
1,01450
,052
-,0177
4,9796
Tenofovir
1,16667
1,01450
,764
-1,3320
3,6653
Naive
1,31429
1,01450
,600
-1,1844
3,8129
-1,16667
1,01450
,764
-3,6653
1,3320
-48000,00000
23081,93038
,126
-104849,7139
8849,7139
34142,85714
23081,93038
,433
-22706,8568
90992,5710
-13857,14286
23081,93038
1,000
-70706,8568
42992,5710
Naive
48000,00000
23081,93038
,126
-8849,7139
104849,7139
Zidovudine
13857,14286
23081,93038
1,000
-42992,5710
70706,8568
Zidovudine
-18,71429
*
3,72136
,000
-27,8798
-9,5487
-14,00000
*
3,72136
,001
-23,1655
-4,8345
18,71429
*
3,72136
,000
9,5487
27,8798
4,71429
3,72136
,630
-4,4513
13,8798
Zidovudine Naive
Tenofovir
Zidovudine
Tenofovir
Zidovudine Naive
Tenofovir
Tenofovir
HDL
Naive
Tenofovir
Zidovudine Naive
Tenofovir
J)
Std. Error
Sig.
Universitas Sumatera Utara
75
Tenofovir
LDL
Naive
*
3,72136
,001
4,8345
23,1655
Zidovudine
-4,71429
3,72136
,630
-13,8798
4,4513
Zidovudine
-31,42857
*
9,63677
,005
-55,1635
-7,6937
-32,95238
*
9,63677
,003
-56,6873
-9,2175
31,42857
*
9,63677
,005
7,6937
55,1635
-1,52381
9,63677
1,000
-25,2587
22,2111
*
9,63677
,003
9,2175
56,6873
1,52381
9,63677
1,000
-22,2111
25,2587
Naive
14,00000
Tenofovir
Zidovudine Naive
Tenofovir
Tenofovir
Naive
32,95238
Zidovudine
*. The mean difference is significant at the 0.05 level.
Proporsi Kadar Lipid berdasarkan kriteria dislipidemia
Kolesterol total
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
>=200 mg/dl
19
30,2
30,2
30,2
< 200 mg/dl
44
69,8
69,8
100,0
Total
63
100,0
100,0
Trigliserida
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
>= 150 mg/dl
18
28,6
28,6
28,6
= 40 mg/dl
32
50,8
50,8
100,0
Total
63
100,0
100,0
LDL
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
>= 130 mg/dl
23
36,5
36,5
36,5
< 130 mg/dl
40
63,5
63,5
100,0
Total
63
100,0
100,0
Universitas Sumatera Utara
76
Dislipidemia
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
ya
50
79,4
79,4
79,4
tidak
13
20,6
20,6
100,0
Total
63
100,0
100,0
jk * Dislipidemia Crosstabulation
Dislipidemia
ya
jk
Laki-laki
Count
8
37
29,4
7,6
37,0
% within jk
78,4%
21,6%
100,0%
% within Dislipidemia
58,0%
61,5%
58,7%
21
5
26
20,6
5,4
26,0
% within jk
80,8%
19,2%
100,0%
% within Dislipidemia
42,0%
38,5%
41,3%
50
13
63
50,0
13,0
63,0
79,4%
20,6%
100,0%
100,0%
100,0%
100,0%
Count
Expected Count
Total
Total
29
Expected Count
Perempuan
tidak
Count
Expected Count
% within jk
% within Dislipidemia
Chi-Square Tests
Value
df
Asymp. Sig. (2-
Exact Sig. (2-
Exact Sig. (1-
sided)
sided)
sided)
a
1
,817
Continuity Correction
,000
1
1,000
Likelihood Ratio
,054
1
,817
Pearson Chi-Square
,053
b
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
1,000
,052
1
,819
63
a. 0 cells (0,0%) have expected count less than 5. The minimum expected count is 5,37.
b. Computed only for a 2x2 table
Universitas Sumatera Utara
,538
77
Risk Estimate
95% Confidence Interval
Value
Odds Ratio for jk (Laki-laki /
,247
3,014
,970
,754
1,249
1,124
,414
3,051
For cohort Dislipidemia = ya
tidak
Upper
,863
Perempuan)
For cohort Dislipidemia =
Lower
N of Valid Cases
63
Descriptives
Dislipidemia
usia
ya
Statistic
Mean
36,2400
95% Confidence Interval for
Lower Bound
33,4539
Mean
Upper Bound
39,0261
5% Trimmed Mean
35,6556
Median
33,0000
Variance
1,38639
96,104
Std. Deviation
9,80329
Minimum
22,00
Maximum
60,00
Range
38,00
Interquartile Range
13,25
Skewness
1,017
,337
,178
,662
31,0000
1,87767
Kurtosis
tidak
Std. Error
Mean
95% Confidence Interval for
Lower Bound
26,9089
Mean
Upper Bound
35,0911
5% Trimmed Mean
30,8889
Median
29,0000
Variance
Std. Deviation
45,833
6,77003
Minimum
21,00
Maximum
43,00
Range
22,00
Interquartile Range
8,50
Universitas Sumatera Utara
78
Skewness
Kurtosis
IMT
ya
Mean
1,191
21,8640
,50907
20,8410
Mean
Upper Bound
22,8870
5% Trimmed Mean
21,6867
Median
21,6000
12,957
3,59965
Minimum
15,90
Maximum
31,00
Range
15,10
Interquartile Range
4,02
Skewness
,765
,337
Kurtosis
,638
,662
22,4462
,69195
Mean
95% Confidence Interval for
Lower Bound
20,9385
Mean
Upper Bound
23,9538
5% Trimmed Mean
22,4457
Median
22,0000
Variance
6,224
Std. Deviation
ya
-,400
Lower Bound
Std. Deviation
CD4
,616
95% Confidence Interval for
Variance
tidak
,324
2,49487
Minimum
17,60
Maximum
27,30
Range
9,70
Interquartile Range
3,30
Skewness
,015
,616
Kurtosis
,458
1,191
252,2400
27,10800
Mean
95% Confidence Interval for
Lower Bound
197,7644
Mean
Upper Bound
306,7156
5% Trimmed Mean
237,9556
Median
207,5000
Variance
36742,186
Std. Deviation
191,68251
Minimum
7,00
Maximum
799,00
Range
792,00
Universitas Sumatera Utara
79
Interquartile Range
tidak
269,00
Skewness
,958
,337
Kurtosis
,733
,662
311,3077
34,46038
Mean
95% Confidence Interval for
Lower Bound
236,2250
Mean
Upper Bound
386,3904
5% Trimmed Mean
312,8974
Median
316,0000
Variance
15437,731
Std. Deviation
124,24867
Minimum
111,00
Maximum
483,00
Range
372,00
Interquartile Range
182,00
Skewness
-,317
,616
Kurtosis
-,901
1,191
Tests of Normality
Kolmogorov-Smirnova
Dislipidemia
usia
IMT
CD4
ya
Statistic
df
,170
Shapiro-Wilk
Sig.
Statistic
df
Sig.
50
,001
,893
50
,000
*
tidak
,175
13
,200
,933
13
,368
ya
,125
50
,049
,944
50
,020
*
tidak
,109
13
,200
,988
13
,999
ya
,111
50
,167
,927
50
,004
tidak
,177
13
,200*
,938
13
,430
*. This is a lower bound of the true significance.
a. Lilliefors Significance Correction
Universitas Sumatera Utara
80
Nonparametric Tests
Rejimen Pengobatan * Dislipidemia Crosstabulation
Dislipidemia
ya
Rejimen Pengobatan
Naive
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
Zidovudine
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
Tenofovir
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
tidak
Total
20
1
21
16,7
4,3
21,0
95,2%
4,8%
100,0%
40,0%
7,7%
33,3%
12
9
21
16,7
4,3
21,0
57,1%
42,9%
100,0%
24,0%
69,2%
33,3%
18
3
21
16,7
4,3
21,0
85,7%
14,3%
100,0%
36,0%
23,1%
33,3%
Universitas Sumatera Utara
81
Total
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
50
13
63
50,0
13,0
63,0
79,4%
20,6%
100,0%
100,0%
100,0%
100,0%
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
sided)
10,080a
2
,006
10,196
2
,006
,572
1
,449
Linear-by-Linear Association
N of Valid Cases
a.
df
63
3 cells (50,0%) have expected count less than 5. The minimum
expected count is 4,33.
Rejimen Pengobatan * Dislipidemia Crosstabulation
Dislipidemia
ya
Rejimen Pengobatan
Naive
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
Zidovudine
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
Total
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
tidak
Total
20
1
21
16,0
5,0
21,0
95,2%
4,8%
100,0%
62,5%
10,0%
50,0%
12
9
21
16,0
5,0
21,0
57,1%
42,9%
100,0%
37,5%
90,0%
50,0%
32
10
42
32,0
10,0
42,0
76,2%
23,8%
100,0%
100,0%
100,0%
100,0%
Universitas Sumatera Utara
82
Chi-Square Tests
Value
Asymp. Sig. (2-
Exact Sig. (2-
Exact Sig. (1-
sided)
sided)
sided)
df
8,400a
1
,004
Continuity Correction
6,431
1
,011
Likelihood Ratio
9,383
1
,002
Pearson Chi-Square
b
Fisher's Exact Test
,009
Linear-by-Linear Association
8,200
N of Valid Cases
1
,004
,004
42
a. 0 cells (0,0%) have expected count less than 5. The minimum expected count is 5,00.
b. Computed only for a 2x2 table
Risk Estimate
95% Confidence Interval
Value
Lower
Upper
Odds Ratio for Rejimen
Pengobatan (Naive /
15,000
1,685
133,551
1,667
1,137
2,443
,111
,015
,801
Zidovudine)
For cohort Dislipidemia = ya
For cohort Dislipidemia =
tidak
N of Valid Cases
42
Rejimen Pengobatan * Dislipidemia Crosstabulation
Dislipidemia
ya
Rejimen Pengobatan
Naive
Count
% within Rejimen
Pengobatan
% within Dislipidemia
Tenofovir
Count
% within Rejimen
Pengobatan
% within Dislipidemia
Total
Count
% within Rejimen
Pengobatan
% within Dislipidemia
tidak
Total
20
1
21
95,2%
4,8%
100,0%
52,6%
25,0%
50,0%
18
3
21
85,7%
14,3%
100,0%
47,4%
75,0%
50,0%
38
4
42
90,5%
9,5%
100,0%
100,0%
100,0%
100,0%
Universitas Sumatera Utara
83
Chi-Square Tests
Value
Pearson Chi-Square
df
Continuity Correction
Likelihood Ratio
Exact Sig. (2-
Exact Sig. (1-
sided)
sided)
sided)
a
1
,293
,276
1
,599
1,152
1
,283
1,105
b
Asymp. Sig. (2-
Fisher's Exact Test
,606
Linear-by-Linear Association
1,079
N of Valid Cases
1
,299
42
a. 2 cells (50,0%) have expected count less than 5. The minimum expected count is 2,00.
b. Computed only for a 2x2 table
Risk Estimate
95% Confidence Interval
Value
Lower
Upper
Odds Ratio for Rejimen
Pengobatan (Naive /
3,333
,318
34,989
1,111
,911
1,356
,333
,038
2,951
Tenofovir)
For cohort Dislipidemia = ya
For cohort Dislipidemia =
tidak
N of Valid Cases
42
Logistic Regression
Categorical Variables Codings
Parameter coding
Frequency
Rejimen Pengobatan
(1)
(2)
Naive
21
,000
,000
Zidovudine
21
1,000
,000
Tenofovir
21
,000
1,000
Universitas Sumatera Utara
,303
84
Block 0: Beginning Block
Classification Tablea,b
Predicted
Dislipidemia
Observed
Step 0
tidak
Dislipidemia
Percentage
ya
Correct
tidak
0
13
,0
ya
0
50
100,0
Overall Percentage
79,4
a. Constant is included in the model.
b. The cut value is ,500
Variables in the Equation
B
Step 0
Constant
S.E.
1,347
Wald
,311
df
Sig.
18,722
1
,000
Exp(B)
3,846
Variables not in the Equation
Score
Step 0
Variables
df
Sig.
usia
3,220
1
,073
CD
1,122
1
,290
10,080
2
,006
rejimen(1)
9,498
1
,002
rejimen(2)
,775
1
,379
14,267
4
,006
rejimen
Overall Statistics
Block 1: Method = Enter
Omnibus Tests of Model Coefficients
Chi-square
Step 1
df
Sig.
Step
16,049
4
,003
Block
16,049
4
,003
Model
16,049
4
,003
Model Summary
Step
1
-2 Log likelihood
48,095a
Cox & Snell R
Nagelkerke R
Square
Square
,225
,352
a. Estimation terminated at iteration number 6 because
parameter estimates changed by less than ,001.
Universitas Sumatera Utara
85
Classification Tablea
Predicted
Dislipidemia
Observed
Step 1
Dislipidemia
tidak
Percentage
ya
Correct
tidak
5
8
38,5
ya
5
45
90,0
Overall Percentage
79,4
a. The cut value is ,500
Variables in the Equation
95% C.I.for EXP(B)
B
a
Step 1
S.E.
Wald
df
Sig.
Exp(B)
Lower
Upper
usia
,112
,055
4,124
1
,042
1,119
1,004
1,246
CD
,000
,002
,039
1
,844
1,000
,995
1,004
8,811
2
,012
rejimen
rejimen(1)
-2,956
1,210
5,966
1
,015
,052
,005
,558
rejimen(2)
-,975
1,261
,598
1
,439
,377
,032
4,463
Constant
-,558
1,999
,078
1
,780
,573
a. Variable(s) entered on step 1: usia, CD, rejimen.
Logistic Regression
Categorical Variables Codings
Parameter coding
Frequency
Rejimen Pengobatan
(1)
(2)
Naive
21
,000
,000
Zidovudine
21
1,000
,000
Tenofovir
21
,000
1,000
Block 0: Beginning Block
Classification Tablea,b
Predicted
Dislipidemia
Observed
Step 0
Dislipidemia
tidak
Percentage
ya
Correct
tidak
0
13
,0
ya
0
50
100,0
Overall Percentage
79,4
a. Constant is included in the model.
b. The cut value is ,500
Universitas Sumatera Utara
86
Variables in the Equation
B
Step 0
Constant
S.E.
1,347
Wald
,311
df
Sig.
18,722
1
,000
Exp(B)
3,846
Variables not in the Equation
Score
Step 0
Variables
usia
df
Sig.
3,220
1
,073
10,080
2
,006
rejimen(1)
9,498
1
,002
rejimen(2)
,775
1
,379
14,262
3
,003
rejimen
Overall Statistics
Block 1: Method = Enter
Omnibus Tests of Model Coefficients
Chi-square
Step 1
df
Sig.
Step
16,011
3
,001
Block
16,011
3
,001
Model
16,011
3
,001
Model Summary
Step
1
Cox & Snell R
Nagelkerke R
Square
Square
-2 Log likelihood
a
48,133
,224
,351
a. Estimation terminated at iteration number 6 because
parameter estimates changed by less than ,001.
Classification Tablea
Predicted
Dislipidemia
Observed
Step 1
Dislipidemia
tidak
Percentage
ya
Correct
tidak
5
8
38,5
ya
5
45
90,0
Overall Percentage
79,4
a. The cut value is ,500
Universitas Sumatera Utara
87
Variables in the Equation
95% C.I.for EXP(B)
B
Step 1a
usia
,112
S.E.
,056
rejimen
Wald
df
Sig.
4,053
1
,044
9,421
2
,009
Exp(B)
Lower
Upper
1,118
1,003
1,247
rejimen(1)
-3,022
1,164
6,745
1
,009
,049
,005
,476
rejimen(2)
-1,035
1,221
,718
1
,397
,355
,032
3,892
Constant
-,634
1,978
,103
1
,749
,531
a. Variable(s) entered on step 1: usia, rejimen.
Universitas Sumatera Utara
88
Lampiran 7
MASTER TABEL
Profil Lipid
NO
Nama
Reji
men
ARV
Umur
(Thn)
Sex
Pen
didi
kan
Pek
erja
an
Ala
mat
Fak
tor
Risi
ko
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
Sh
SMS
ES
MS
AW
SAN
JS
OT
AS
HS
Bi
SS
EPS
Kp
SG
EPD
RA
JJS
NG
MLT
AN
Si
PS
DHA
ER
LS
Bu
SSS
MK
RM
HS
RKM
KH
LM
HHDM
AB
AS
BST
Ar
NS
MT
MF
He
DIN
Id
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
28
44
36
54
33
29
28
33
36
39
39
33
35
51
38
30
22
28
28
49
27
51
43
42
21
31
35
35
29
54
37
27
43
38
32
28
29
60
28
29
41
31
32
36
26
2
2
1
1
1
2
1
2
1
1
2
1
1
2
2
1
2
1
2
2
1
2
1
2
1
1
1
2
1
1
1
1
2
2
1
1
1
2
2
2
1
2
1
1
1
3
5
3
3
5
5
3
2
4
2
3
3
3
1
2
3
3
3
4
2
3
1
2
4
3
5
1
3
5
1
5
5
3
1
5
1
3
3
3
5
3
3
5
5
5
2
5
1
1
1
5
5
2
6
1
2
4
1
2
3
1
3
6
2
4
1
3
7
1
8
6
1
1
3
1
1
1
5
2
6
6
1
2
3
6
1
3
6
1
5
3
5
5
9
7
7
7
1
3
3
1
9
1
3
5
5
4
3
3
4
10
2
3
3
3
3
3
1
3
11
3
6
11
9
3
1
3
5
3
9
3
5
3
8
3
1
1
1
1
5
1
1
1
1
1
4
1
1
1
1
1
1
6
1
5
1
1
1
1
2
1
2
6
1
1
1
1
1
1
1
1
3
1
1
1
1
1
1
1
2
IMT
CD4
(Cell/
Ul)
18.6
20.8
15.9
18.2
21.9
20.8
21.3
23
22.4
25.6
21.2
16
19.1
20.7
23.8
16.9
22.2
21.2
27.3
21.6
16.6
21.8
24.3
20
17.6
22.8
22
26.1
23.5
30.9
18.1
22
24.9
21.6
23.4
21.3
20.8
26.2
19.9
24
25
31
22.9
27
20.8
92
170
13
15
467
279
385
34
150
25
136
85
43
244
301
7
344
16
235
150
19
181
112
387
400
396
479
266
199
633
301
92
294
316
480
382
441
578
289
387
197
198
332
94
225
Koleste
rol total
(mg/dL)
Triglis
erida
(mg/d
L)
HDL
(mg/
dL)
LDL
(mg/d
L)
120
143
127
128
160
135
154
133
123
138
165
150
99
186
135
174
239
129
151
122
140
195
179
215
153
159
196
223
232
197
171
176
219
171
172
195
202
223
188
169
144
205
231
264
222
162
107
163
132
135
56
197
156
83
149
73
143
126
136
111
179
88
53
109
105
129
128
113
182
84
95
109
235
98
117
148
181
205
60
221
122
46
134
76
48
73
108
124
346
129
22
15
12
34
29
36
25
38
22
29
38
34
17
37
35
35
53
32
41
34
32
29
45
35
43
54
42
35
70
47
62
35
54
71
34
61
63
52
47
45
51
68
42
35
50
55
88
76
87
105
94
101
62
80
81
139
97
64
131
90
93
160
78
99
61
82
142
114
144
93
100
122
140
211
140
149
107
132
88
103
109
114
143
125
106
71
130
144
153
128
Universitas Sumatera Utara
89
Profil Lipid
NO
Nama
Reji
men
ARV
Umur
(Thn)
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
Fi
TH
DSN
JL
MAR
JS
HLPN
TF
MAH
RH
HLT
JDB
Jr
TT
DMM
Zu
LE
PS
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
28
32
30
24
25
33
47
28
30
36
34
43
21
58
29
30
29
60
Sex
2
2
1
1
2
1
1
1
2
2
1
1
1
2
1
1
2
1
Pen
didi
kan
Pek
erja
an
Ala
mat
Fak
tor
Risi
ko
3
3
5
5
3
2
3
3
3
3
5
5
3
1
3
3
3
5
3
3
6
6
3
1
1
1
6
1
1
1
2
4
1
1
6
2
3
3
3
3
3
3
3
3
3
4
3
3
3
5
3
3
3
1
1
1
1
2
1
1
1
2
1
1
1
2
2
1
5
1
1
1
IMT
CD4
(Cell/
Ul)
19
21.8
22
30.4
19.9
17.5
22
20.4
19.5
21.9
20.8
22.7
23.8
17.1
24.6
18.7
21.6
28.3
207
111
208
200
360
287
287
483
129
464
113
761
260
160
507
84
799
370
Koleste
rol total
(mg/dL)
Triglis
erida
(mg/d
L)
HDL
(mg/
dL)
LDL
(mg/d
L)
184
109
195
263
231
219
196
156
257
105
130
146
157
176
242
236
217
281
140
105
79
152
76
200
215
68
156
30
111
214
39
122
355
131
100
328
37
47
41
67
73
45
27
51
42
25
25
64
56
34
41
64
41
37
108
81
144
172
143
134
126
85
179
46
72
106
77
101
130
153
150
183
KETERANGAN MASTER TABEL
Rejimen ARV
(1) Naïve
(2) Zidovudine
(3) Tenofovir
Jenis Kelamin
(1) Laki-laki
(2) Perempuan
Pendidikan
(1) SD
(2) SMP
(3) SMA
(4) Akademi
(5) Sarjana S1
Pekerjaan
(1) Wiraswasta
(2) Tidak bekerja
(3) Ibu Rumah Tangga
(4) Petani
(5) PNS
(6) Karyawan swasta
(7) Supir
(8) Mahasiswa
Alamat
(1) Tanah Karo
(2) Binjai
(3) Medan
(4) Sibolga
(5) Deli Serdang
(6) Nias
(7) Aceh
(8) P. Siantar
(9) Simalungun
(10) Tobasa
(11) Dairi
Faktor Risiko
(1) Heteroseksual
(2) Homoseksual
(3) Biseksual
(4) Transfusi
(5) IDU
(6) Heteroseksual, Tatto
Universitas Sumatera Utara
Lampiran 1: Surat Persetujuan Komite Etik
Universitas Sumatera Utara
54
Lampiran 2
LEMBAR PENJELASAN KEPADA CALON SUBJEK PENELITIAN
Selamat pagi/siang Bapak/Ibu/Saudara/I, pada hari ini saya, dr.Eva
Roswati, peserta Pendidikan Pasca Sarjana Ilmu Penyakit Dalam / Magister
Klinik FK USU Medan akan melakukan penelitian yang berjudul ” Pengaruh
pemberian rejimen antiretroviral (ARV) yang mengandung Zidovudine atau
Tenofovir terhadap kadar lipid pada orang dengan HIV/AIDS (ODHA)”.
Penelitian ini bertujuan melihat pengaruh pemberian obat antiretroviral yang
mengandung Zidovudine atau Tenofovir selama 6 bulan terhadap kadar lipid
serum. Sebagai informasi, yang dikatakan sebagai penderita HIV-AIDS adalah
subyek yang terinfeksi virus HIV yang memerlukan terapi obat anti virus untuk
mengobati penyakitnya. Diperlukan kepatuhan untuk meminum obat anti virus
tersebut agar keberhasilan terapi dapat tercapai. Namun demikian, pemberian obat
anti virus juga mempengaruhi kadar lipid. Untuk itu peneliti ingin mengetahui
apakah ada hubungan antara obat tersebut dengan kadar lipid .
Bapak/Ibu/Saudara/Saudari yang bersedia mengikuti penelitian ini
nantinya akan diminta mengisi surat persetujuan ikut dalam penelitian, mengikuti
wawancara untuk mencari adanya hal-hal yang dapat mengganggu penelitian.
Untuk penelitian ini akan dilakukan pengambilan darah pada daerah lipatan siku
Bapak/Ibu/Saudara/i sebanyak ±15 cc (1 sendok makan) oleh ahlinya untuk
pemeriksaan darah rutin, fungsi hati, fungsi ginjal, kadar glukosa darah, kadar
lipid setelah Bapak/Ibu berpuasa 12-16jam semalam sebelum pengambilan darah.
Di akhir minggu ke 24 nantinya akan dilakukan pemeriksaan ulangan untuk
menilai efek apakah terdapat pengaruh dalam hal ini: kadar lipid dari pemberian
obat antiretroviral yang telah Bapak/Ibu/Saudara/Saudari minum. Segala biaya
pemeriksaan laboratorium menjadi tanggung jawab peneliti. Bila masih terdapat
pertanyaan atau keluhan sewaktu penelitian ini berjalan, maka
Bapak/Ibu/Saudara/Saudari dapat menghubungi saya pada:
Nama
: dr.Eva Roswati
Alamat
: Jl. Gajah Mada No. 14 Medan
Telepon
: 08116074047
Atas Perhatian Bapak/Ibu, Saudara/i saya ucapkan terima kasih.
Peneliti,
(dr.Eva Roswati)
Universitas Sumatera Utara
55
Lampiran 3
LEMBAR PERSETUJUAN SETELAH PENJELASAN
(INFORMED CONSENT)
Saya yang bertandatangan di bawah ini:
Nama
: ............................................................................
Alamat
: ............................................................................
Umur
: ............................................................................
Jenis Kelamin
: Laki-laki/ Perempuan
No Telp
: ............................................................................
Setelah mendapat penjelasan dari peneliti tentang kebaikan dan keburukan
prosedur penelitian ini, saya menyatakan bersedia ikut serta dalam penelitian
tentang
“Pengaruh
pemberian
rejimen
antiretroviral
(ARV)
yang
mengandung Zidovudine atau Tenofovir terhadap kadar lipid pada orang
dengan HIV/AIDS (ODHA)”. Apabila sewaktu-waktu saya mengudurkan diri
dari penelitian ini, kepada saya tidak dituntut apapun.
Demikian surat persetujuan bersedia ikut dalam penelitian ini saya buat untuk
dapat dipergunakan seperlunya.
Medan, ……………..
Saksi
(_________________ )
Yang memberi pernyataan
(_________________ )
Universitas Sumatera Utara
56
Lampiran 4
KERTAS KERJA PROFIL PESERTA PENELITIAN
I. IDENTITAS PRIBADI.
Nama
Umur
Jenis Kelamin
Pendidikan Terakhir
Pekerjaan
Alamat
Faktor resiko
Nomor Rekam Medis
: .............................
: .............................
: Laki-laki/Perempuan.
: .............................
: .............................
: .............................
: ……………………
: ……………………
II.PEMERIKSAAN FISIK
Parameter Antropometri
Berat Badan (kg)
Tinggi Badan (m2)
Indeks Massa Tubuh (kg/m2 )
Hasil
III.PEMERIKSAAN LABORATORIUM
Parameter Metabolik
Hemoglobin
Hematokrit
Trombosit
Lekosit
Hitung jenis lekosit
Ureum
Kreatinin
SGOT
SGPT
Kadar Glukosa Darah
CD4
Kolesterol total
Trigliserid
HDL kolesterol
LDL kolesterol
EKG
Hasil
Universitas Sumatera Utara
57
Lampiran 5
DAFTAR RIWAYAT HIDUP
I.
II.
Identitas Pribadi
Nama
: dr. Eva Roswati
Tempat/Tgl Lahir
: Jakarta/ 24 November 1977
Suku/Bangsa
: Batak/ Indonesia
Agama
: Kristen Protestan
Status
: Menikah
Alamat
: Jl. Gajah Mada Gg. Sersan No. 14 Medan
Telpon Selluler
: 08116074047
Keluarga
Nama suami
: Ir. Sarma Aries H. Lumban Gaol
Anak
: 1. Josh Richard Lumban Gaol
2. Daireann Ersah Lumban Gaol
III.
IV.
Pendidikan
SDN 09 Pagi Ragunan, Jakarta
Tamat Tahun 1989
SMPN 175 Jagakarsa, Jakarta
Tamat Tahun 1992
SMAN 28 Pasar Minggu, Jakarta
Tamat Tahun 1995
Fakultas Kedokteran Universitas Sumatera Utara
Tamat Tahun 2001
PPDS Ilmu Penyakit Dalam FK USU
2010 - sekarang
Riwayat Pekerjaan
Dokter ICU RSPAD Gatot Soebroto, Jakarta
Dokter PTT RSU Dr. Hadrianus Sinaga Pangururan, Samosir
Dokter UGD RSPAD Gatot Soebroto, Jakarta
Staf Pusat Penanggulangan Krisis Kemenkes RI, Jakarta
Universitas Sumatera Utara
58
V.
Perkumpulan Profesi
Anggota IDI Cabang Medan
Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI)
VI.
Tulisan Ilmiah
1. Diagnosis dan Tatalaksana Koagulasi Intravaskular Diseminata pada
Sepsis
2. Insufisiensi adrenal pada pasien dengan penyakit kritis
3. Dispepsia Tukak : Diagnosis dan Manajemen
4. Makna Klinis Kadar Troponin T pada penyakit jantung
5. Pemakaian Obat-obat sistemik pada penyakit ginjal kronik
6. Acute Respiratory Distress Syndrome
7. Manifestasi Klinis dari Alergi Makanan
8. Penggunaan sistem skor sebagai panduan thromboprofilaksis pada
populasi ibu hamil dengan resiko tinggi
9. Bagaimana manifestasi jiwa yang sehat
VII. Publikasi Ilmiah
1. Sindroma
Cushing
Iatrogenik
dan
Dermatitis
Eksfoliativa
Generalisata: Laporan Kasus. 4 th Endocrinology & Diabetes Forum
Of Sumatera Region. Banda Aceh, 2012.
2. Pengalaman Menangani Kasus Serial Malaria Berat di RS H.Adam
Malik Tahun 2011 – Mei 2012 : Laporan Kasus. PETRI, Banda Aceh,
2012
VIII. Partisipasi Dalam Kegiatan Ilmiah
1. Peserta Simposium “The New Option of Insulin Resistance Treatment
in Type 2 Diabetes”, Hermes Palace Hotel Medan, 20 November 2011
2. Panitia “Current Challenges Management on Infections”. PETRISUMUT. Hotel Danau Toba International. Medan 26-27 November
2011.
Universitas Sumatera Utara
59
3. Peserta Simposium “Rationale Strategy in the Management of
Pancreatic B Dysfunction and Role of Oral Incretin Based Therapy in
Type 2 Diabetes Mellitus”, Hotel J.W. Marriott Medan, 29 Januari
2012.
4. Peserta Simposium The New Direction in The Treatment of Type 2
Diabetes Melitus “A New Novel DPP-4 Inhibitor For T2DM
Treatment”, Hotel J.W. Marriott Medan, 1 April 2012
5. Peserta Roadshow Hipertensi PB PAPDI “The Next Big Target in
Hypertension: Controlling All Key BP Parameters”, Hotel J.W.
Marriott Medan, 28 April 2012
6. Peserta Seminar dan Lokakarya Sehari: Comperhensive Management
of Nausea-Vomiting and Acid Related Diseases, 5 Mei 2012.
7. Peserta Simposium “Diagnostik dan Manajemen Terkini di Bidang
Ilmu Penyakit Dalam, Fokus pada Infeksi”. PIT Penyakit Dalam XIII
& Infection Update V. Hotel Danau Toba Internasional. Medan, 9-10
Juni 2012.
8. Peserta Simposium Kongres Nasional XV Perhimpunan Dokter
Spesialis Penyakit Dalam Indonesia (KOPAPDI XV), Hotel J.W.
Marriott dan Hotel Grand Aston Medan, 12-15 Desember 2012
9. Peserta Workshop USG PAD, FEDS V, Hotel Grand Aston Medan,
Februari 2013
10. Panitia Workshop & Simposium “Meningkatkan Kemampuan Dalam
Menghadapi Penyakit Infeksi Masa Kini” Infection Update VI. PETRI
SUMUT. Hotel Danau Toba Internasional. Medan 6-7 September
2013.
11. Peserta Workshop “USG”. Pertemuan Ilmiah Tahunan Ilmu Penyakit
Dalam XIV & Gastroentero-Hepatologi Update XI. Hotel Tiara
Convention Center. Medan 12-14 September 2013.
12. Peserta Workshop & Simposium Medan Chest and Clinical
Immunology (MCCI). Hotel Tiara Convention Center. Medan, 5-7
Desember 2013.
Universitas Sumatera Utara
60
Lampiran 6
HASIL STATISTIK
Karakteristik Dasar Subjek Penelitian
Crosstab Jenis kelamin
rejimen
Naive
jk
Laki-laki
Count
Total
Zidovudine
Tenofovir
11
12
14
37
12,3
12,3
12,3
37,0
% within jk
29,7%
32,4%
37,8%
100,0%
% within rejimen
52,4%
57,1%
66,7%
58,7%
Count
10
9
7
26
Expected Count
8,7
8,7
8,7
26,0
% within jk
38,5%
34,6%
26,9%
100,0%
% within rejimen
47,6%
42,9%
33,3%
41,3%
21
21
21
63
21,0
21,0
21,0
63,0
33,3%
33,3%
33,3%
100,0%
100,0%
100,0%
100,0%
100,0%
Expected Count
Perempuan
Total
Count
Expected Count
% within jk
% within rejimen
Chi-Square Tests
Asymp. Sig. (2Value
df
sided)
a
2
,632
Likelihood Ratio
,926
2
,629
Linear-by-Linear Association
,870
1
,351
Pearson Chi-Square
N of Valid Cases
,917
63
a. 0 cells (0,0%) have expected count less than 5. The minimum expected count is 8,67.
Universitas Sumatera Utara
61
Crosstab Pendidikan
rejimen
Naive
pendidikan
SD
Count
1
7
2,3
2,3
2,3
7,0
14,3%
71,4%
14,3%
100,0%
4,8%
23,8%
4,8%
11,1%
4
1
1
6
2,0
2,0
2,0
6,0
% within pendidikan
66,7%
16,7%
16,7%
100,0%
% within rejimen
19,0%
4,8%
4,8%
9,5%
11
8
11
30
10,0
10,0
10,0
30,0
% within pendidikan
36,7%
26,7%
36,7%
100,0%
% within rejimen
52,4%
38,1%
52,4%
47,6%
2
1
0
3
1,0
1,0
1,0
3,0
66,7%
33,3%
0,0%
100,0%
9,5%
4,8%
0,0%
4,8%
3
6
8
17
5,7
5,7
5,7
17,0
% within pendidikan
17,6%
35,3%
47,1%
100,0%
% within rejimen
14,3%
28,6%
38,1%
27,0%
21
21
21
63
21,0
21,0
21,0
63,0
33,3%
33,3%
33,3%
100,0%
100,0%
100,0%
100,0%
100,0%
% within rejimen
Count
Expected Count
Count
Expected Count
AKADEMI
Count
Expected Count
% within pendidikan
% within rejimen
SARJANA
Count
Expected Count
Total
Total
5
% within pendidikan
SMA
Tenofovir
1
Expected Count
SMP
Zidovudine
Count
Expected Count
% within pendidikan
% within rejimen
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases
df
sided)
12,407a
8
,134
12,788
8
,119
1,779
1
,182
63
a. 9 cells (60,0%) have expected count less than 5. The minimum
expected count is 1,00.
Universitas Sumatera Utara
62
Crosstab Pekerjaan
rejimen
Naive
pekerjaan
swasta
Count
9
24
8,0
8,0
8,0
24,0
% within pekerjaan
29,2%
33,3%
37,5%
100,0%
% within rejimen
33,3%
38,1%
42,9%
38,1%
5
2
2
9
3,0
3,0
3,0
9,0
% within pekerjaan
55,6%
22,2%
22,2%
100,0%
% within rejimen
23,8%
9,5%
9,5%
14,3%
2
4
3
9
3,0
3,0
3,0
9,0
22,2%
44,4%
33,3%
100,0%
9,5%
19,0%
14,3%
14,3%
2
0
1
3
1,0
1,0
1,0
3,0
66,7%
0,0%
33,3%
100,0%
9,5%
0,0%
4,8%
4,8%
3
1
1
5
1,7
1,7
1,7
5,0
% within pekerjaan
60,0%
20,0%
20,0%
100,0%
% within rejimen
14,3%
4,8%
4,8%
7,9%
2
4
5
11
3,7
3,7
3,7
11,0
18,2%
36,4%
45,5%
100,0%
9,5%
19,0%
23,8%
17,5%
Count
0
1
0
1
Expected Count
,3
,3
,3
1,0
% within pekerjaan
0,0%
100,0%
0,0%
100,0%
% within rejimen
0,0%
4,8%
0,0%
1,6%
Count
0
1
0
1
Expected Count
,3
,3
,3
1,0
% within pekerjaan
0,0%
100,0%
0,0%
100,0%
% within rejimen
0,0%
4,8%
0,0%
1,6%
21
21
21
63
21,0
21,0
21,0
63,0
Count
Count
Expected Count
% within pekerjaan
% within rejimen
Petani
Count
Expected Count
% within pekerjaan
% within rejimen
PNS
Count
Expected Count
Swasta
Count
Expected Count
% within pekerjaan
% within rejimen
Supir
Mahasiswa
Total
Total
8
Expected Count
IRT
Tenofovir
7
Expected Count
Tidak Bekerja
Zidovudine
Count
Expected Count
Universitas Sumatera Utara
63
% within pekerjaan
% within rejimen
33,3%
33,3%
33,3%
100,0%
100,0%
100,0%
100,0%
100,0%
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
df
14
,623
12,818
14
,541
,050
1
,824
11,789
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases
sided)
a
63
a. 21 cells (87,5%) have expected count less than 5. The minimum
expected count is ,33.
Crosstab Faktor Risiko
rejimen
Naive
FR
Heteroseksual
Count
Transfusi
15
49
16,3
16,3
16,3
49,0
% within FR
34,7%
34,7%
30,6%
100,0%
% within rejimen
81,0%
81,0%
71,4%
77,8%
0
2
5
7
2,3
2,3
2,3
7,0
% within FR
0,0%
28,6%
71,4%
100,0%
% within rejimen
0,0%
9,5%
23,8%
11,1%
Count
0
1
0
1
Expected Count
,3
,3
,3
1,0
% within FR
0,0%
100,0%
0,0%
100,0%
% within rejimen
0,0%
4,8%
0,0%
1,6%
Count
1
0
0
1
Expected Count
,3
,3
,3
1,0
100,0%
0,0%
0,0%
100,0%
4,8%
0,0%
0,0%
1,6%
2
0
1
3
1,0
1,0
1,0
3,0
66,7%
0,0%
33,3%
100,0%
9,5%
0,0%
4,8%
4,8%
1
1
0
2
Count
% within FR
% within rejimen
IDU
Count
Expected Count
% within FR
% within rejimen
Hetero Tatto
Total
17
Expected Count
Bisexual
Tenofovir
17
Expected Count
Homoseksual
Zidovudine
Count
Universitas Sumatera Utara
64
Expected Count
% within FR
,7
,7
,7
2,0
50,0%
50,0%
0,0%
100,0%
4,8%
4,8%
0,0%
3,2%
21
21
21
63
21,0
21,0
21,0
63,0
33,3%
33,3%
33,3%
100,0%
100,0%
100,0%
100,0%
100,0%
% within rejimen
Total
Count
Expected Count
% within FR
% within rejimen
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
df
10
,247
15,959
10
,101
,726
1
,394
12,592
Likelihood Ratio
sided)
a
Linear-by-Linear Association
N of Valid Cases
63
a. 15 cells (83,3%) have expected count less than 5. The minimum
expected count is ,33.
Descriptives Usia, IMT dan CD4
rejimen
usia
Naive
Statistic
Mean
35,2381
95% Confidence Interval for
Lower Bound
31,3786
Mean
Upper Bound
39,0976
5% Trimmed Mean
34,9259
Median
33,0000
Variance
1,85023
71,890
Std. Deviation
Zidovudine
Std. Error
8,47883
Minimum
22,00
Maximum
54,00
Range
32,00
Interquartile Range
11,00
Skewness
,826
,501
Kurtosis
,105
,972
36,3810
2,14640
Mean
95% Confidence Interval for
Lower Bound
31,9036
Mean
Upper Bound
40,8583
5% Trimmed Mean
35,9233
Median
35,0000
Variance
96,748
Universitas Sumatera Utara
65
Std. Deviation
Tenofovir
9,83604
Minimum
21,00
Maximum
60,00
Range
39,00
Interquartile Range
13,50
Skewness
,893
,501
Kurtosis
,410
,972
33,8571
2,23744
Mean
95% Confidence Interval for
Lower Bound
29,1899
Mean
Upper Bound
38,5244
5% Trimmed Mean
33,1164
Median
30,0000
Variance
105,129
Std. Deviation
10,25322
Minimum
21,00
Maximum
60,00
Range
39,00
Interquartile Range
IMT
Naive
8,00
Skewness
1,534
,501
Kurtosis
1,959
,972
20,7190
,65526
Mean
95% Confidence Interval for
Lower Bound
19,3522
Mean
Upper Bound
22,0859
5% Trimmed Mean
20,6254
Median
21,2000
Variance
9,017
Std. Deviation
3,00277
Minimum
15,90
Maximum
27,30
Range
11,40
Interquartile Range
3,90
Skewness
,165
,501
-,037
,972
23,2000
,75763
Kurtosis
Zidovudine
Mean
95% Confidence Interval for
Lower Bound
21,6196
Mean
Upper Bound
24,7804
5% Trimmed Mean
23,0767
Median
22,8000
Universitas Sumatera Utara
66
Variance
12,054
Std. Deviation
Tenofovir
3,47189
Minimum
17,60
Maximum
31,00
Range
13,40
Interquartile Range
3,90
Skewness
,775
,501
Kurtosis
,830
,972
22,0333
,73515
Mean
95% Confidence Interval for
Lower Bound
20,4998
Mean
Upper Bound
23,5668
5% Trimmed Mean
21,8471
Median
21,8000
Variance
11,349
Std. Deviation
CD4
Naive
3,36888
Minimum
17,10
Maximum
30,40
Range
13,30
Interquartile Range
3,65
Skewness
,962
,501
Kurtosis
,897
,972
152,8571
30,47077
Mean
95% Confidence Interval for
Lower Bound
89,2962
Mean
Upper Bound
216,4181
5% Trimmed Mean
143,7090
Median
136,0000
Variance
19497,829
Std. Deviation
139,63463
Minimum
7,00
Maximum
467,00
Range
460,00
Interquartile Range
239,50
Skewness
Kurtosis
Zidovudine
Mean
,772
,501
-,427
,972
333,7143
31,44369
95% Confidence Interval for
Lower Bound
268,1239
Mean
Upper Bound
399,3047
5% Trimmed Mean
330,6085
Universitas Sumatera Utara
67
Median
316,0000
Variance
20762,814
Std. Deviation
144,09308
Minimum
92,00
Maximum
633,00
Range
541,00
Interquartile Range
222,00
Skewness
,243
,501
-,360
,972
306,7143
44,09493
Kurtosis
Tenofovir
Mean
95% Confidence Interval for
Lower Bound
214,7339
Mean
Upper Bound
398,6947
5% Trimmed Mean
291,8122
Median
260,0000
Variance
40831,614
Std. Deviation
202,06834
Minimum
84,00
Maximum
799,00
Range
715,00
Interquartile Range
272,50
Skewness
1,225
,501
Kurtosis
1,100
,972
Tests of Normality Usia, IMT, CD4
Kolmogorov-Smirnova
rejimen
usia
IMT
CD4
Statistic
Naive
df
,138
Shapiro-Wilk
Sig.
Statistic
df
Sig.
21
,200*
,923
21
,098
*
Zidovudine
,148
21
,200
,926
21
,115
Tenofovir
,227
21
,006
,830
21
,002
Naive
,164
21
,144
,958
21
,486
*
Zidovudine
,112
21
,200
,939
21
,206
Tenofovir
,171
21
,113
,930
21
,139
Naive
,165
21
,138
,892
21
,024
*
Zidovudine
,111
21
,200
,974
21
,810
Tenofovir
,158
21
,185
,876
21
,012
*. This is a lower bound of the true significance.
a. Lilliefors Significance Correction
Universitas Sumatera Utara
68
Profil Lipid berdasarkan rejimen pengobatan
Descriptives kadar profil lipid
rejimen
kolest
Naive
Statistic
Mean
145,2857
95% Confidence Interval for
Lower Bound
131,9491
Mean
Upper Bound
158,6223
5% Trimmed Mean
142,7354
Median
138,0000
Variance
29,29871
Minimum
99,00
Maximum
239,00
Range
140,00
Interquartile Range
29,50
Skewness
1,685
,501
Kurtosis
4,431
,972
189,7143
5,38169
Mean
95% Confidence Interval for
Lower Bound
178,4883
Mean
Upper Bound
200,9403
5% Trimmed Mean
189,9048
Median
195,0000
Variance
608,214
Std. Deviation
Tenofovir
6,39350
858,414
Std. Deviation
Zidovudine
Std. Error
24,66200
Minimum
144,00
Maximum
232,00
Range
88,00
Interquartile Range
39,00
Skewness
-,031
,501
Kurtosis
-,856
,972
200,8095
11,31342
Mean
95% Confidence Interval for
Lower Bound
177,2101
Mean
Upper Bound
224,4089
5% Trimmed Mean
201,7116
Median
217,0000
Variance
2687,862
Std. Deviation
51,84459
Universitas Sumatera Utara
69
trigliserid
Naive
Zidovudine
Minimum
105,00
Maximum
281,00
Range
176,00
Interquartile Range
82,50
Skewness
-,394
,501
Kurtosis
-,832
,972
123,4286
8,44691
Mean
95% Confidence Interval for
Lower Bound
105,8086
Mean
Upper Bound
141,0485
5% Trimmed Mean
123,2937
Median
129,0000
Variance
1498,357
Std. Deviation
38,70862
Minimum
53,00
Maximum
197,00
Range
144,00
Interquartile Range
56,00
Skewness
-,151
,501
Kurtosis
-,455
,972
123,0000
11,97299
Mean
95% Confidence Interval for
Lower Bound
98,0248
Mean
Upper Bound
147,9752
5% Trimmed Mean
121,0873
Median
113,0000
Variance
3010,400
Std. Deviation
54,86711
Minimum
46,00
Maximum
235,00
Range
189,00
Interquartile Range
84,50
Skewness
Kurtosis
Tenofovir
Mean
,620
,501
-,410
,972
153,3333
20,41957
95% Confidence Interval for
Lower Bound
110,7389
Mean
Upper Bound
195,9278
5% Trimmed Mean
148,9815
Median
129,0000
Variance
8756,133
Std. Deviation
93,57421
Universitas Sumatera Utara
70
Minimum
30,00
Maximum
355,00
Range
325,00
Interquartile Range
117,50
Skewness
Kurtosis
HDL
Naive
Mean
,487
,972
30,9524
2,08335
Lower Bound
26,6066
Mean
Upper Bound
35,2982
5% Trimmed Mean
30,8042
Median
34,0000
91,148
Std. Deviation
9,54713
Minimum
12,00
Maximum
53,00
Range
41,00
Interquartile Range
13,00
Skewness
-,142
,501
,556
,972
49,6667
2,75451
Kurtosis
Mean
95% Confidence Interval for
Lower Bound
43,9209
Mean
Upper Bound
55,4125
5% Trimmed Mean
49,6190
Median
47,0000
Variance
159,333
Std. Deviation
12,62273
Minimum
29,00
Maximum
71,00
Range
42,00
Interquartile Range
23,00
Skewness
Kurtosis
Tenofovir
,501
95% Confidence Interval for
Variance
Zidovudine
1,076
Mean
,193
,501
-,979
,972
44,9524
2,97408
95% Confidence Interval for
Lower Bound
38,7486
Mean
Upper Bound
51,1562
5% Trimmed Mean
44,5185
Median
42,0000
Variance
185,748
Std. Deviation
13,62893
Universitas Sumatera Utara
71
Minimum
25,00
Maximum
73,00
Range
48,00
Interquartile Range
17,50
Skewness
Kurtosis
LDL
Naive
Mean
-,398
,972
91,5714
5,68103
Lower Bound
79,7210
Mean
Upper Bound
103,4219
5% Trimmed Mean
89,8413
Median
88,0000
Variance
677,757
26,03377
Minimum
55,00
Maximum
160,00
Range
105,00
Interquartile Range
23,00
Skewness
1,121
,501
Kurtosis
1,429
,972
123,0000
6,36134
Mean
95% Confidence Interval for
Lower Bound
109,7305
Mean
Upper Bound
136,2695
5% Trimmed Mean
121,1190
Median
122,0000
Variance
849,800
Std. Deviation
Tenofovir
,501
95% Confidence Interval for
Std. Deviation
Zidovudine
,504
29,15133
Minimum
71,00
Maximum
211,00
Range
140,00
Interquartile Range
36,50
Skewness
1,094
,501
Kurtosis
3,165
,972
124,5238
8,15844
Mean
95% Confidence Interval for
Lower Bound
107,5056
Mean
Upper Bound
141,5420
5% Trimmed Mean
125,5794
Median
130,0000
Universitas Sumatera Utara
72
Variance
1397,762
Std. Deviation
37,38665
Minimum
46,00
Maximum
183,00
Range
137,00
Interquartile Range
58,50
Skewness
-,371
,501
Kurtosis
-,571
,972
Tests of Normality
Kolmogorov-Smirnova
rejimen
kolest
trigliserid
HDL
LDL
Naive
Statistic
,150
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
21
,200*
,869
21
,009
*
Zidovudine
,109
21
,200
,970
21
,733
Tenofovir
,146
21
,200*
,955
21
,417
21
*
,981
21
,935
*
Naive
,098
,200
Zidovudine
,135
21
,200
,941
21
,229
Tenofovir
,203
21
,024
,880
21
,015
Naive
,163
21
,150
,948
21
,313
*
Zidovudine
,115
21
,200
,953
21
,387
Tenofovir
,157
21
,190
,946
21
,284
Naive
,168
21
,124
,908
21
,050
21
*
,918
21
,078
*
,964
21
,591
Zidovudine
Tenofovir
,140
,135
21
,200
,200
Universitas Sumatera Utara
73
Uji Kruskal Wallis
Universitas Sumatera Utara
74
UJI ANOVA
Sum of Squares
IMT
Between Groups
df
2
32,353
Within Groups
648,399
60
10,807
Total
713,104
62
335648571428,5
Total
Sig.
2,994
,058
13,683
,000
7,451
,001
60 5594142857,143
71
361280857142,8
62
57
LDL
F
64,705
Within Groups
HDL
Mean Square
Between Groups
3979,143
2
1989,571
Within Groups
8724,571
60
145,410
Total
12703,714
62
Between Groups
14531,556
2
7265,778
Within Groups
58506,381
60
975,106
Total
73037,937
62
Post Hoc Tests
Multiple Comparisons
Bonferroni
Dependent
95% Confidence Interval
Mean Difference (I-
Variable
(I) rejimen
(J) rejimen
Lower Bound
Upper Bound
IMT
Naive
Zidovudine
-2,48095
1,01450
,052
-4,9796
,0177
Tenofovir
-1,31429
1,01450
,600
-3,8129
1,1844
2,48095
1,01450
,052
-,0177
4,9796
Tenofovir
1,16667
1,01450
,764
-1,3320
3,6653
Naive
1,31429
1,01450
,600
-1,1844
3,8129
-1,16667
1,01450
,764
-3,6653
1,3320
-48000,00000
23081,93038
,126
-104849,7139
8849,7139
34142,85714
23081,93038
,433
-22706,8568
90992,5710
-13857,14286
23081,93038
1,000
-70706,8568
42992,5710
Naive
48000,00000
23081,93038
,126
-8849,7139
104849,7139
Zidovudine
13857,14286
23081,93038
1,000
-42992,5710
70706,8568
Zidovudine
-18,71429
*
3,72136
,000
-27,8798
-9,5487
-14,00000
*
3,72136
,001
-23,1655
-4,8345
18,71429
*
3,72136
,000
9,5487
27,8798
4,71429
3,72136
,630
-4,4513
13,8798
Zidovudine Naive
Tenofovir
Zidovudine
Tenofovir
Zidovudine Naive
Tenofovir
Tenofovir
HDL
Naive
Tenofovir
Zidovudine Naive
Tenofovir
J)
Std. Error
Sig.
Universitas Sumatera Utara
75
Tenofovir
LDL
Naive
*
3,72136
,001
4,8345
23,1655
Zidovudine
-4,71429
3,72136
,630
-13,8798
4,4513
Zidovudine
-31,42857
*
9,63677
,005
-55,1635
-7,6937
-32,95238
*
9,63677
,003
-56,6873
-9,2175
31,42857
*
9,63677
,005
7,6937
55,1635
-1,52381
9,63677
1,000
-25,2587
22,2111
*
9,63677
,003
9,2175
56,6873
1,52381
9,63677
1,000
-22,2111
25,2587
Naive
14,00000
Tenofovir
Zidovudine Naive
Tenofovir
Tenofovir
Naive
32,95238
Zidovudine
*. The mean difference is significant at the 0.05 level.
Proporsi Kadar Lipid berdasarkan kriteria dislipidemia
Kolesterol total
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
>=200 mg/dl
19
30,2
30,2
30,2
< 200 mg/dl
44
69,8
69,8
100,0
Total
63
100,0
100,0
Trigliserida
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
>= 150 mg/dl
18
28,6
28,6
28,6
= 40 mg/dl
32
50,8
50,8
100,0
Total
63
100,0
100,0
LDL
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
>= 130 mg/dl
23
36,5
36,5
36,5
< 130 mg/dl
40
63,5
63,5
100,0
Total
63
100,0
100,0
Universitas Sumatera Utara
76
Dislipidemia
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
ya
50
79,4
79,4
79,4
tidak
13
20,6
20,6
100,0
Total
63
100,0
100,0
jk * Dislipidemia Crosstabulation
Dislipidemia
ya
jk
Laki-laki
Count
8
37
29,4
7,6
37,0
% within jk
78,4%
21,6%
100,0%
% within Dislipidemia
58,0%
61,5%
58,7%
21
5
26
20,6
5,4
26,0
% within jk
80,8%
19,2%
100,0%
% within Dislipidemia
42,0%
38,5%
41,3%
50
13
63
50,0
13,0
63,0
79,4%
20,6%
100,0%
100,0%
100,0%
100,0%
Count
Expected Count
Total
Total
29
Expected Count
Perempuan
tidak
Count
Expected Count
% within jk
% within Dislipidemia
Chi-Square Tests
Value
df
Asymp. Sig. (2-
Exact Sig. (2-
Exact Sig. (1-
sided)
sided)
sided)
a
1
,817
Continuity Correction
,000
1
1,000
Likelihood Ratio
,054
1
,817
Pearson Chi-Square
,053
b
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
1,000
,052
1
,819
63
a. 0 cells (0,0%) have expected count less than 5. The minimum expected count is 5,37.
b. Computed only for a 2x2 table
Universitas Sumatera Utara
,538
77
Risk Estimate
95% Confidence Interval
Value
Odds Ratio for jk (Laki-laki /
,247
3,014
,970
,754
1,249
1,124
,414
3,051
For cohort Dislipidemia = ya
tidak
Upper
,863
Perempuan)
For cohort Dislipidemia =
Lower
N of Valid Cases
63
Descriptives
Dislipidemia
usia
ya
Statistic
Mean
36,2400
95% Confidence Interval for
Lower Bound
33,4539
Mean
Upper Bound
39,0261
5% Trimmed Mean
35,6556
Median
33,0000
Variance
1,38639
96,104
Std. Deviation
9,80329
Minimum
22,00
Maximum
60,00
Range
38,00
Interquartile Range
13,25
Skewness
1,017
,337
,178
,662
31,0000
1,87767
Kurtosis
tidak
Std. Error
Mean
95% Confidence Interval for
Lower Bound
26,9089
Mean
Upper Bound
35,0911
5% Trimmed Mean
30,8889
Median
29,0000
Variance
Std. Deviation
45,833
6,77003
Minimum
21,00
Maximum
43,00
Range
22,00
Interquartile Range
8,50
Universitas Sumatera Utara
78
Skewness
Kurtosis
IMT
ya
Mean
1,191
21,8640
,50907
20,8410
Mean
Upper Bound
22,8870
5% Trimmed Mean
21,6867
Median
21,6000
12,957
3,59965
Minimum
15,90
Maximum
31,00
Range
15,10
Interquartile Range
4,02
Skewness
,765
,337
Kurtosis
,638
,662
22,4462
,69195
Mean
95% Confidence Interval for
Lower Bound
20,9385
Mean
Upper Bound
23,9538
5% Trimmed Mean
22,4457
Median
22,0000
Variance
6,224
Std. Deviation
ya
-,400
Lower Bound
Std. Deviation
CD4
,616
95% Confidence Interval for
Variance
tidak
,324
2,49487
Minimum
17,60
Maximum
27,30
Range
9,70
Interquartile Range
3,30
Skewness
,015
,616
Kurtosis
,458
1,191
252,2400
27,10800
Mean
95% Confidence Interval for
Lower Bound
197,7644
Mean
Upper Bound
306,7156
5% Trimmed Mean
237,9556
Median
207,5000
Variance
36742,186
Std. Deviation
191,68251
Minimum
7,00
Maximum
799,00
Range
792,00
Universitas Sumatera Utara
79
Interquartile Range
tidak
269,00
Skewness
,958
,337
Kurtosis
,733
,662
311,3077
34,46038
Mean
95% Confidence Interval for
Lower Bound
236,2250
Mean
Upper Bound
386,3904
5% Trimmed Mean
312,8974
Median
316,0000
Variance
15437,731
Std. Deviation
124,24867
Minimum
111,00
Maximum
483,00
Range
372,00
Interquartile Range
182,00
Skewness
-,317
,616
Kurtosis
-,901
1,191
Tests of Normality
Kolmogorov-Smirnova
Dislipidemia
usia
IMT
CD4
ya
Statistic
df
,170
Shapiro-Wilk
Sig.
Statistic
df
Sig.
50
,001
,893
50
,000
*
tidak
,175
13
,200
,933
13
,368
ya
,125
50
,049
,944
50
,020
*
tidak
,109
13
,200
,988
13
,999
ya
,111
50
,167
,927
50
,004
tidak
,177
13
,200*
,938
13
,430
*. This is a lower bound of the true significance.
a. Lilliefors Significance Correction
Universitas Sumatera Utara
80
Nonparametric Tests
Rejimen Pengobatan * Dislipidemia Crosstabulation
Dislipidemia
ya
Rejimen Pengobatan
Naive
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
Zidovudine
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
Tenofovir
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
tidak
Total
20
1
21
16,7
4,3
21,0
95,2%
4,8%
100,0%
40,0%
7,7%
33,3%
12
9
21
16,7
4,3
21,0
57,1%
42,9%
100,0%
24,0%
69,2%
33,3%
18
3
21
16,7
4,3
21,0
85,7%
14,3%
100,0%
36,0%
23,1%
33,3%
Universitas Sumatera Utara
81
Total
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
50
13
63
50,0
13,0
63,0
79,4%
20,6%
100,0%
100,0%
100,0%
100,0%
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
sided)
10,080a
2
,006
10,196
2
,006
,572
1
,449
Linear-by-Linear Association
N of Valid Cases
a.
df
63
3 cells (50,0%) have expected count less than 5. The minimum
expected count is 4,33.
Rejimen Pengobatan * Dislipidemia Crosstabulation
Dislipidemia
ya
Rejimen Pengobatan
Naive
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
Zidovudine
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
Total
Count
Expected Count
% within Rejimen
Pengobatan
% within Dislipidemia
tidak
Total
20
1
21
16,0
5,0
21,0
95,2%
4,8%
100,0%
62,5%
10,0%
50,0%
12
9
21
16,0
5,0
21,0
57,1%
42,9%
100,0%
37,5%
90,0%
50,0%
32
10
42
32,0
10,0
42,0
76,2%
23,8%
100,0%
100,0%
100,0%
100,0%
Universitas Sumatera Utara
82
Chi-Square Tests
Value
Asymp. Sig. (2-
Exact Sig. (2-
Exact Sig. (1-
sided)
sided)
sided)
df
8,400a
1
,004
Continuity Correction
6,431
1
,011
Likelihood Ratio
9,383
1
,002
Pearson Chi-Square
b
Fisher's Exact Test
,009
Linear-by-Linear Association
8,200
N of Valid Cases
1
,004
,004
42
a. 0 cells (0,0%) have expected count less than 5. The minimum expected count is 5,00.
b. Computed only for a 2x2 table
Risk Estimate
95% Confidence Interval
Value
Lower
Upper
Odds Ratio for Rejimen
Pengobatan (Naive /
15,000
1,685
133,551
1,667
1,137
2,443
,111
,015
,801
Zidovudine)
For cohort Dislipidemia = ya
For cohort Dislipidemia =
tidak
N of Valid Cases
42
Rejimen Pengobatan * Dislipidemia Crosstabulation
Dislipidemia
ya
Rejimen Pengobatan
Naive
Count
% within Rejimen
Pengobatan
% within Dislipidemia
Tenofovir
Count
% within Rejimen
Pengobatan
% within Dislipidemia
Total
Count
% within Rejimen
Pengobatan
% within Dislipidemia
tidak
Total
20
1
21
95,2%
4,8%
100,0%
52,6%
25,0%
50,0%
18
3
21
85,7%
14,3%
100,0%
47,4%
75,0%
50,0%
38
4
42
90,5%
9,5%
100,0%
100,0%
100,0%
100,0%
Universitas Sumatera Utara
83
Chi-Square Tests
Value
Pearson Chi-Square
df
Continuity Correction
Likelihood Ratio
Exact Sig. (2-
Exact Sig. (1-
sided)
sided)
sided)
a
1
,293
,276
1
,599
1,152
1
,283
1,105
b
Asymp. Sig. (2-
Fisher's Exact Test
,606
Linear-by-Linear Association
1,079
N of Valid Cases
1
,299
42
a. 2 cells (50,0%) have expected count less than 5. The minimum expected count is 2,00.
b. Computed only for a 2x2 table
Risk Estimate
95% Confidence Interval
Value
Lower
Upper
Odds Ratio for Rejimen
Pengobatan (Naive /
3,333
,318
34,989
1,111
,911
1,356
,333
,038
2,951
Tenofovir)
For cohort Dislipidemia = ya
For cohort Dislipidemia =
tidak
N of Valid Cases
42
Logistic Regression
Categorical Variables Codings
Parameter coding
Frequency
Rejimen Pengobatan
(1)
(2)
Naive
21
,000
,000
Zidovudine
21
1,000
,000
Tenofovir
21
,000
1,000
Universitas Sumatera Utara
,303
84
Block 0: Beginning Block
Classification Tablea,b
Predicted
Dislipidemia
Observed
Step 0
tidak
Dislipidemia
Percentage
ya
Correct
tidak
0
13
,0
ya
0
50
100,0
Overall Percentage
79,4
a. Constant is included in the model.
b. The cut value is ,500
Variables in the Equation
B
Step 0
Constant
S.E.
1,347
Wald
,311
df
Sig.
18,722
1
,000
Exp(B)
3,846
Variables not in the Equation
Score
Step 0
Variables
df
Sig.
usia
3,220
1
,073
CD
1,122
1
,290
10,080
2
,006
rejimen(1)
9,498
1
,002
rejimen(2)
,775
1
,379
14,267
4
,006
rejimen
Overall Statistics
Block 1: Method = Enter
Omnibus Tests of Model Coefficients
Chi-square
Step 1
df
Sig.
Step
16,049
4
,003
Block
16,049
4
,003
Model
16,049
4
,003
Model Summary
Step
1
-2 Log likelihood
48,095a
Cox & Snell R
Nagelkerke R
Square
Square
,225
,352
a. Estimation terminated at iteration number 6 because
parameter estimates changed by less than ,001.
Universitas Sumatera Utara
85
Classification Tablea
Predicted
Dislipidemia
Observed
Step 1
Dislipidemia
tidak
Percentage
ya
Correct
tidak
5
8
38,5
ya
5
45
90,0
Overall Percentage
79,4
a. The cut value is ,500
Variables in the Equation
95% C.I.for EXP(B)
B
a
Step 1
S.E.
Wald
df
Sig.
Exp(B)
Lower
Upper
usia
,112
,055
4,124
1
,042
1,119
1,004
1,246
CD
,000
,002
,039
1
,844
1,000
,995
1,004
8,811
2
,012
rejimen
rejimen(1)
-2,956
1,210
5,966
1
,015
,052
,005
,558
rejimen(2)
-,975
1,261
,598
1
,439
,377
,032
4,463
Constant
-,558
1,999
,078
1
,780
,573
a. Variable(s) entered on step 1: usia, CD, rejimen.
Logistic Regression
Categorical Variables Codings
Parameter coding
Frequency
Rejimen Pengobatan
(1)
(2)
Naive
21
,000
,000
Zidovudine
21
1,000
,000
Tenofovir
21
,000
1,000
Block 0: Beginning Block
Classification Tablea,b
Predicted
Dislipidemia
Observed
Step 0
Dislipidemia
tidak
Percentage
ya
Correct
tidak
0
13
,0
ya
0
50
100,0
Overall Percentage
79,4
a. Constant is included in the model.
b. The cut value is ,500
Universitas Sumatera Utara
86
Variables in the Equation
B
Step 0
Constant
S.E.
1,347
Wald
,311
df
Sig.
18,722
1
,000
Exp(B)
3,846
Variables not in the Equation
Score
Step 0
Variables
usia
df
Sig.
3,220
1
,073
10,080
2
,006
rejimen(1)
9,498
1
,002
rejimen(2)
,775
1
,379
14,262
3
,003
rejimen
Overall Statistics
Block 1: Method = Enter
Omnibus Tests of Model Coefficients
Chi-square
Step 1
df
Sig.
Step
16,011
3
,001
Block
16,011
3
,001
Model
16,011
3
,001
Model Summary
Step
1
Cox & Snell R
Nagelkerke R
Square
Square
-2 Log likelihood
a
48,133
,224
,351
a. Estimation terminated at iteration number 6 because
parameter estimates changed by less than ,001.
Classification Tablea
Predicted
Dislipidemia
Observed
Step 1
Dislipidemia
tidak
Percentage
ya
Correct
tidak
5
8
38,5
ya
5
45
90,0
Overall Percentage
79,4
a. The cut value is ,500
Universitas Sumatera Utara
87
Variables in the Equation
95% C.I.for EXP(B)
B
Step 1a
usia
,112
S.E.
,056
rejimen
Wald
df
Sig.
4,053
1
,044
9,421
2
,009
Exp(B)
Lower
Upper
1,118
1,003
1,247
rejimen(1)
-3,022
1,164
6,745
1
,009
,049
,005
,476
rejimen(2)
-1,035
1,221
,718
1
,397
,355
,032
3,892
Constant
-,634
1,978
,103
1
,749
,531
a. Variable(s) entered on step 1: usia, rejimen.
Universitas Sumatera Utara
88
Lampiran 7
MASTER TABEL
Profil Lipid
NO
Nama
Reji
men
ARV
Umur
(Thn)
Sex
Pen
didi
kan
Pek
erja
an
Ala
mat
Fak
tor
Risi
ko
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
Sh
SMS
ES
MS
AW
SAN
JS
OT
AS
HS
Bi
SS
EPS
Kp
SG
EPD
RA
JJS
NG
MLT
AN
Si
PS
DHA
ER
LS
Bu
SSS
MK
RM
HS
RKM
KH
LM
HHDM
AB
AS
BST
Ar
NS
MT
MF
He
DIN
Id
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
28
44
36
54
33
29
28
33
36
39
39
33
35
51
38
30
22
28
28
49
27
51
43
42
21
31
35
35
29
54
37
27
43
38
32
28
29
60
28
29
41
31
32
36
26
2
2
1
1
1
2
1
2
1
1
2
1
1
2
2
1
2
1
2
2
1
2
1
2
1
1
1
2
1
1
1
1
2
2
1
1
1
2
2
2
1
2
1
1
1
3
5
3
3
5
5
3
2
4
2
3
3
3
1
2
3
3
3
4
2
3
1
2
4
3
5
1
3
5
1
5
5
3
1
5
1
3
3
3
5
3
3
5
5
5
2
5
1
1
1
5
5
2
6
1
2
4
1
2
3
1
3
6
2
4
1
3
7
1
8
6
1
1
3
1
1
1
5
2
6
6
1
2
3
6
1
3
6
1
5
3
5
5
9
7
7
7
1
3
3
1
9
1
3
5
5
4
3
3
4
10
2
3
3
3
3
3
1
3
11
3
6
11
9
3
1
3
5
3
9
3
5
3
8
3
1
1
1
1
5
1
1
1
1
1
4
1
1
1
1
1
1
6
1
5
1
1
1
1
2
1
2
6
1
1
1
1
1
1
1
1
3
1
1
1
1
1
1
1
2
IMT
CD4
(Cell/
Ul)
18.6
20.8
15.9
18.2
21.9
20.8
21.3
23
22.4
25.6
21.2
16
19.1
20.7
23.8
16.9
22.2
21.2
27.3
21.6
16.6
21.8
24.3
20
17.6
22.8
22
26.1
23.5
30.9
18.1
22
24.9
21.6
23.4
21.3
20.8
26.2
19.9
24
25
31
22.9
27
20.8
92
170
13
15
467
279
385
34
150
25
136
85
43
244
301
7
344
16
235
150
19
181
112
387
400
396
479
266
199
633
301
92
294
316
480
382
441
578
289
387
197
198
332
94
225
Koleste
rol total
(mg/dL)
Triglis
erida
(mg/d
L)
HDL
(mg/
dL)
LDL
(mg/d
L)
120
143
127
128
160
135
154
133
123
138
165
150
99
186
135
174
239
129
151
122
140
195
179
215
153
159
196
223
232
197
171
176
219
171
172
195
202
223
188
169
144
205
231
264
222
162
107
163
132
135
56
197
156
83
149
73
143
126
136
111
179
88
53
109
105
129
128
113
182
84
95
109
235
98
117
148
181
205
60
221
122
46
134
76
48
73
108
124
346
129
22
15
12
34
29
36
25
38
22
29
38
34
17
37
35
35
53
32
41
34
32
29
45
35
43
54
42
35
70
47
62
35
54
71
34
61
63
52
47
45
51
68
42
35
50
55
88
76
87
105
94
101
62
80
81
139
97
64
131
90
93
160
78
99
61
82
142
114
144
93
100
122
140
211
140
149
107
132
88
103
109
114
143
125
106
71
130
144
153
128
Universitas Sumatera Utara
89
Profil Lipid
NO
Nama
Reji
men
ARV
Umur
(Thn)
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
Fi
TH
DSN
JL
MAR
JS
HLPN
TF
MAH
RH
HLT
JDB
Jr
TT
DMM
Zu
LE
PS
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
28
32
30
24
25
33
47
28
30
36
34
43
21
58
29
30
29
60
Sex
2
2
1
1
2
1
1
1
2
2
1
1
1
2
1
1
2
1
Pen
didi
kan
Pek
erja
an
Ala
mat
Fak
tor
Risi
ko
3
3
5
5
3
2
3
3
3
3
5
5
3
1
3
3
3
5
3
3
6
6
3
1
1
1
6
1
1
1
2
4
1
1
6
2
3
3
3
3
3
3
3
3
3
4
3
3
3
5
3
3
3
1
1
1
1
2
1
1
1
2
1
1
1
2
2
1
5
1
1
1
IMT
CD4
(Cell/
Ul)
19
21.8
22
30.4
19.9
17.5
22
20.4
19.5
21.9
20.8
22.7
23.8
17.1
24.6
18.7
21.6
28.3
207
111
208
200
360
287
287
483
129
464
113
761
260
160
507
84
799
370
Koleste
rol total
(mg/dL)
Triglis
erida
(mg/d
L)
HDL
(mg/
dL)
LDL
(mg/d
L)
184
109
195
263
231
219
196
156
257
105
130
146
157
176
242
236
217
281
140
105
79
152
76
200
215
68
156
30
111
214
39
122
355
131
100
328
37
47
41
67
73
45
27
51
42
25
25
64
56
34
41
64
41
37
108
81
144
172
143
134
126
85
179
46
72
106
77
101
130
153
150
183
KETERANGAN MASTER TABEL
Rejimen ARV
(1) Naïve
(2) Zidovudine
(3) Tenofovir
Jenis Kelamin
(1) Laki-laki
(2) Perempuan
Pendidikan
(1) SD
(2) SMP
(3) SMA
(4) Akademi
(5) Sarjana S1
Pekerjaan
(1) Wiraswasta
(2) Tidak bekerja
(3) Ibu Rumah Tangga
(4) Petani
(5) PNS
(6) Karyawan swasta
(7) Supir
(8) Mahasiswa
Alamat
(1) Tanah Karo
(2) Binjai
(3) Medan
(4) Sibolga
(5) Deli Serdang
(6) Nias
(7) Aceh
(8) P. Siantar
(9) Simalungun
(10) Tobasa
(11) Dairi
Faktor Risiko
(1) Heteroseksual
(2) Homoseksual
(3) Biseksual
(4) Transfusi
(5) IDU
(6) Heteroseksual, Tatto
Universitas Sumatera Utara